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ABSTRACT 
Corn offers a number of advantages as production host for low- and intermediate- 
value protein-based products that could be produced in large volume as co-products of corn 
based biorefining. We selected one such potential product, a recombinant human 100 kDa 
type I collagen alpha 1 (CIα1) and a 44 kDa single chain fragment (a gelatin). The 
equivalency to the intended product was established by characterizing the immuno-
recognition, molecular weight, amino acid composition and sequence, and post-translational 
modifications.  
Purification for characterization of the recombinant proteins from transgenic corn 
grain began with protein extraction in 0.1M phosphoric acid buffer. The use of low pH 
minimized the extraction of host components while allowing efficient recovery of both 44 
kDa and 100 kDa CIα1s. The 44 kDa CIα1 was purified by a two-step process consisting of 
ion-exchange chromatography followed by a gel filtration chromatography, resulting in 70% 
purity and 60% yield.  The N-terminal sequence, amino acid composition and 
immunoreactivity of the purified 44 kDa CIα1 was similar to that of an analogous 44 kDa 
CIα1 fragment produced by yeast Pichia. The corn-derived 44 kDa CIα1 fragment had an 
intact protein mass of 44,088 kDa that was within 0.2% of the mass calculated from the 
intended sequence. 78% coverage of the primary sequence of the corn-derived 44 kDa CIα1 
was confirmed with tandem mass spectrometry. Glycoprotein staining of the 44 kDa CIα1 
revealed no detectable glycosylation.   
The 100 kDa CIα1 was purified to close to 100% purity and 16% yield by using 
membrane filtration followed by four chromatographic steps (two cation-exchange, one 
 v
hydrophobic interaction, and one gel filtration chromatography). The 1.2% hydroxyproline in 
the corn-derived 100 kDa CIα1, corresponding to about 10% of the hydroxyproline content 
in native human collagens, confirmed both some ability of corn to hydroxylate proline, but 
also the necessity of co-expression of a heterologous P4H if higher content is desired. The 
low hydroxyproline content was well correlated with its relatively low melting temperate 
(26oC vs 40oC in native human collagen). A fraction of the expressed CIα1 formed triple 
helices resistant to pepsin hydrolysis.  A 29 amino acid foldon at the C-terminus was not 
cleaved from the CIα1 chains but could be removed by pepsin treatment. The amino acid 
composition and immunoreactivity of the purified CIα1 was as expected and similar to that 
of an analogous CIα1 produced by the yeast Pichia.   
The evidence that the CIα1s accumulated in corn grain with the intended composition 
and post-translational modifications established transgenic corn as a viable way to produce 
this particular full-length 100 kDa CIα1 and its 44kD CIα1 fragment, and potentially other 
“designer” gelatins with specific molecular weights and properties tailored to suit various 
material property specifications. 
Two milling processes have been evaluated for their potential to reduce the 
downstream cost by enriching the CIα1s in fractionated tissues prior to protein extraction and 
purification. Both dry-milling and wet-milling processes were able to concentrate and capture 
ca. 60% of the total CIα1s in ca. 20-25% of the total kernel mass. The 44 kDa and 100 kDa 
CIα1s were enriched 2.5 and 5.8 times respectively in the dry-milled germ-rich fractions 
compared to whole corn kernel. For the wet milling, the 44 kDa CIα1 was captured in fine 
fiber-, coarse fiber-, and gluten-rich fractions with 7.7 times enrichment, and the 100 kDa 
CIα1 was recovered in fine fiber-, coarse fiber-, and germ-rich fractions with 4.6 times 
 vi
enrichment. In summary, both milling processes can increase the CIα1 purity in selected 
fractions. While wet and dry milling achieved similar performance in enriching the 100 kDa 
CIα1, wet milling is superior to dry milling in enriching the 44 kDa CIα1, as the former 
achieved higher purity in the extract and higher purification factor (PF).  CIα1s were 
associated with both coarse fiber and fine fiber when wet-milled, but the mechanism behind 
that discovery was not clear. While the main advantage offered by fractionation is the 
reduction in volume and impurity load to the separation train, an initial on-farm dry-milling 
step would eliminate the need to transport viable transgenic seeds, thus reducing risk of 
accidental release.   
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CHAPTER 1. GENERAL INTRODUCTION 
Motivation and Objectives 
Corn has been one of the most important crops for food and animal feed and, 
industrially, for the production of biofuel, adhesives, and sweeteners. Additional uses of corn 
can come from recombinant technology, which could provide transgenic varieties to produce 
therapeutics and industrial enzymes at large volume and low cost, potentially as co-products 
of corn-based biorefining.  We selected two such potential high volume products, a 
recombinant collagen and a single chain fragment of collagen (a gelatin), to demonstrate the 
feasibility of producing recombinant industrial proteins compatible with economical co-
production in a corn-based biorefinery. Over 50,000 metric tons of collagens and gelatins 
(denatured collagens) are consumed annually for pharmaceutical use, with more than 80%   
used for capsule manufacturing. Most of the gelatins are derived from bovine or porcine bone 
or skin as a co-product of the meat production industry. Use of animal-derived products 
especially in pharmaceutical applications results in allergenicity and safety concerns related 
to animal-derived contaminants, lack of traceability, and inconsistent product quality due to 
the variability of tissue origin and animal age. Plants as bio-factories have the potential to 
eliminate those problems and achieve a safe and consistent product.  
The current research was to 1) develop strategies to recover and purify a low 
expression level recombinant human collagen I alpha 1 (CIα1) chain and a 44 kDa CIα1 
fragment from transgenic corn seeds; 2) investigate the accuracy and efficacy of the 
transgenic corn expression system for the correct production of those two recombinant 
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proteins; and 3) evaluate the effectiveness of  two well-established milling systems (dry and 
wet milling) for  producing kernel fractions enriched in recombinant proteins, thus reducing 
the downstream process burden and enabling integration of recombinant protein production 
into a corn biorefinery. 
We started with purification and characterization of a 44 kDa CIα1 fragment that was  
expressed in corn at a level of 20 mg of 44 kDa CIα1/kg corn seed, permitting recovery of 
sufficient material from the transgenic grain for characterization. We then developed the 
more challenging recovery of the full-length 100 kDa human CIα1 chain expressed at the 
very low level of 3 mg 100 kDa CIα1/kg corn seed. We evaluated the use of conventional, 
non-affinity chromatography to accomplish that task. We focused the characterization of the 
100 kDa CIα1 on its functional and structural properties. These results provided information 
as to how well the corn was capable of processing the synthesized single chains to a mature 
collagen, especially carrying out the post-translational modification and assembly of the 
triple-helical structure.     
Our industrial partners who produced the transgenic grain had targeted expression of 
the proteins to the corn germ as a strategy to boost expression level and enable plant tissue 
fractionation to reduce matrix contaminants in the protein extracts. We evaluated the two 
well-established milling systems to separate corn kernel into different fractions and 
monitored the distribution of the two recombinant collagens. The information obtained could 
be used to assist choosing the best strategy for recovery and purification.   
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Dissertation Format  
This dissertation is arranged in five chapters. References are listed at the end of the 
chapter in which they are cited. Chapter 1 provides background information relating to 
collagen fundamentals, recombinant collagen production by yeast and plant expression 
systems, with emphasis placed on purification process development and protein property 
characterization. Chapters 2-4 are manuscripts being submitted for publication that describe 
the experimental work discussed above. Chapter 2 describes the purification and 
characterization of the 44 kDa CIα1 fragment. Chapter 3 evaluates the expression of the 100 
kDa CIα1, with focus placed on the development and optimization of the purification process 
and evaluation of the expressed protein’s structural and functional properties. Chapter 4 
compares the distributions of the two recombinant CIα1s in the fractions generated by two 
well-established milling processes and assesses their suitability for the subsequent extraction 
and purification process. Finally, the last chapter (Chapter 5) summarizes the overall 
conclusions and proposes future work.           
 
 Literature Review 
Native Collagens and Gelatins 
Collagens are a family of extracellular proteins with an essential role to maintain the 
function and structure of the tissues by providing them with mechanical properties. They are 
amply distributed in bone, cartilage, tendon, cornea, and ligament. There are at least 27 types 
of collagens identified in humans based on genome information (Baez et al. 2005). Gelatins 
used commercially are denatured collagens produced from bovine or porcine bones or skins 
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by acid or base extraction as a co-product of the meat production industry. Over 50,000 
metric tons of collagens and gelatins are consumed every year just for medical uses.  They 
are used as biomaterials in pharmaceutical applications, such as capsules for the oral delivery 
of drugs and vaccine stabilizers, and in tissue engineering applications such as corneal 
implants (Xie et al. 2001), hemostats and bone grafts (Yang et al. 2004a; Yang et al. 2004b). 
Other applications are described in several good reviews (Friess 1998; Lee et al. 2001). 
 
Structure 
 The basic structure of collagen is a triple-helix consisting of three peptide chains, 
called α chains. Each chain is characterized by repeating Gly-X-Y motifs. X and Y can be 
any amino acid except glycine, and are often proline or hydroxyproline (Gelse et al. 2003; 
Myllyharju and Kivirikko 2004). For every three amino acids, a glycine, which is the 
smallest amino acid, is required to fit inside the triple-helix to achieve compact structure 
along the central axis of the molecule. For the human type I collagen α1 chain (termed CIα1), 
which is the target of this work, the triple-helix collagenous domain usually contains about 
1000 amino acids and results in 300 nm length. While the triple-helix structures endow the 
molecules with exceptional tensile strength, the non-collagenous domains located at both 
ends play important roles in helping form the packed structure (Figure 1). C-propeptide is 
thought to initiate the formation of triple-helical structure by aligning the C-terminal domains 
of the three α chains, and the process propagates towards the N terminus. The function of the 
N-propeptide is not fully understood, and is believed to regulate the size of the fibrils. The 
non-helical telopeptide is able to assist covalent cross-linking within collagen molecules 
themselves and between collagen molecules and other surrounding molecules (Gelse et al. 
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 2003).    
  
Figure 1. Molecular structure of type I collagen (Reprinted from (Gelse et al. 2003), with 
permission from Elsevier.) 
 
Collagen Synthesis and Post-translational Modification 
Procollagen molecules, which include both triple-helical region, C- and N-
telopeptides, and C- and N-propeptides, undergo a series of posttranslational modification 
after they are directed into the lumen of the endoplasmic reticulum (ER) by the signal peptide 
which is then usually cleaved off immediately. The conversion to mature collagen (with C- 
and N-propeptide properly cleaved) relies on the proper post-translational processing of the 
nascent procollagen. One of the most important modifications is hydroxylation of proline 
residues which usually occurs on either C3 or C4 sites to form 3-hydroxyproline or 4-
hydroxyproline, respectively. While the function of 3-hydroxyproline is unknown, the 4-
hydroxyproline is essential to forming the intramolecular hydrogen bonds that provide the 
thermal stability of the triple-helical structure. In addition, the 4-hydroxyproline assists the 
formation of intermolecular cross-linking between collagen molecules to develop stable 
fibrils. The content of the hydroxyproline directly affects the collagen’s melting point Tm. 
About 50% of the proline in bovine type-I collagen are hydroxylated and the corresponding 
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Tm is ~ 42oC (Merle et al. 2002). The hydroxylation can also take place on lysine residues. 
The hydroxylysine residues contribute to the fibril integrity and represent the potential site 
for the attachment of sugar groups (Gelse et al. 2003). The sugar components are either the 
monosaccharide galactose or the disaccharide of galactose and glucose, linked to the 
hydroxylysine residues. The function of the hydroxylysine glycosylation is not yet fully 
understood, but it is thought to affect fibril formation (Myllyharju 2005). It is in the ER that 
procollagens form the triple-helical structure with the assistance of the C-propeptide.   
After procollagen assembly and processing, the triple-helical molecules are secreted 
into the extracellular space via the Golgi apparatus, and they continue to undergo processing 
and modification to form fibrils, which is directed by the information encoded in the collagen 
structures. Both C-propeptides and N-propeptides are cleaved by specific processing 
enzymes during or following secretion, the N and C-proteinases (Koide and Nagata 2005), 
and the cleavage of the C-propeptide is thought to be essential for regulating the fibril self- 
assembly. Baez’s work showed that expression without N-propeptides gave a correct folding, 
suggesting the N-propeptide did not play an important role in collagen assembly (Baez et al. 
2005).  Fibril structures are further stabilized by the formation of cross-linking between 
collagen molecules, and it is the hydroxylysine residues in the telopeptides that are 
responsible for the cross-linking formation (Gelse et al. 2003). The correct formation of 
fibrils is indispensable for collagens to maintain their functions such as high tensile strength. 
 
Recombinant Collagen and Gelatin Production 
Use of animal-derived products, especially in pharmaceutical applications, results in 
allergenicity and safety concerns related to animal-derived contaminants, lack of traceability, 
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and inconsistent product quality due to the variability of tissue origin and animal age. Those 
products represent potential sources pathogens (Asher 1999) and allergens. An allergic 
reaction was observed on injection of the α2 chain of bovine type I collagen (Sakaguchi et al. 
1999). In addition, the animal-derived collagens, especially the gelatins, are mixtures of 
proteins lacking uniformity in size, pI (isoelectric point), structure, composition and gelling 
points. They also show lot-to-lot variability. The safety concerns and unpredictability 
associated with the animal-derived collagens and gelatins prompt the development of 
transgenic plant sources without those drawbacks.  
  
Pichia-derived Recombinant Collagens and Gelatins 
While the accumulation of recombinant collagen and of collagen fragments has been 
demonstrated in many other recombinant expression systems such as mammalian cells 
(Fertala et al. 1994; Fichard et al. 1997; Geddis and Prockop 1993), insect cell culture 
(Myllyharju et al. 1997; Nokelainen et al. 1996), Escherichia coli (Cappello 1990; Goldberg 
et al. 1989), Bacillus (Kajino et al. 2000), silkworms (Tomita et al. 2003), milk of transgenic 
animals (John et al. 1999; Toman et al. 1999) and other yeasts (Sacchromyces cerevisiae 
(Olsen et al. 2001; Vaughan et al. 1998), Hansenula polymorpha (de Bruin et al. 2002; 
Geerlings et al. 2007),  the current preferred recombinant technology for collagen and gelatin 
production is based on Pichia yeast fermentation (Baez et al. 2005; Olsen et al. 2003).   
FibroGen Inc., a biopharmaceutical company based in South San Francisco CA, has 
demonstrated commercial production of Pichia-derived recombinant collagens and gelatins 
for pharmaceutical application. Since type I collagen is the most abundant type of collagen, 
the following discussion will mostly focus on the type I collagen.  
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During the synthesis of recombinant collagens, the majority of procollagens 
expressed in Pichia pastoris cannot be secreted into the extracellular medium, but are found 
to accumulate within the ER of the cells even when the authentic signal sequence of the 
collagen was replaced with the S. cerevisiae α mating factor pre-pro sequence; The latter was 
reported to be a more efficient signal sequence than the authentic one (Keizer-Gunnink et al. 
2000; Pakkanen et al. 2006; Vuorela et al. 1997).  Both the triple-helical conformation and 
large size of the procollagens ( trimer, ~270 kDa) were found to adversely affect secretion 
(Pakkanen et al. 2006). It is necessary to lyse the cells by external forces to release the 
procollagens, which are then converted to collagens by the controlled treatment with 
proteases, commonly human pepsin to remove C-and N-propeptides. By careful manipulation 
of gene types and optimizing fermentation processing parameters, expression levels higher 
than 1 g/l can be achieved (Baez et al. 2005).The recombinant collagens produced from 
Pichia pastoris contain a majority of monomers, with only 5-10% cross-linked dimers and a 
minor amount of trimers. Compared to the animal-derived collagens that usually consist of 
more than 50% dimers, trimers and higher order oligomers, the recombinant collagens 
produced from Pichia pastoris show much higher homogeneity (Olsen et al. 2003).   
Prolyl 4-hydroxylase (P4H), a α2β2 tetramer commonly found in vertebrates, is 
believed to play a crucial role in forming stable triple-helical collagens, as well as fibril 
structure. P4H can hydroxylate proline residues, and as mentioned before, the resulting 
hydroxyproline is capable of forming intramolecular hydrogen bonding within the collagen 
molecules and assisting the development of intermolecular cross-linking within fibrils 
(between collagen molecules), key steps for a stable conformation. However, no P4H activity 
could be found in either yeasts or bacteria, which means the recombinant collagens expressed 
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could be in a non-triple-helical and non-functional state. Co-expression of P4H gene with 
collagen, therefore, is usually required in yeasts to get the correct triple-helical structure 
(Vuorela et al. 1997). The successful co-expression of human P4H with recombinant human 
type I-III collagens has been demonstrated in the yeast P. pastoris where two subunits of 
P4H formed an active α2β2 tetramer, which effectively hydroxylated the procollagen chains 
resulting in the correct triple-helical structure. The mature collagen showed hydroxyproline 
content and Tm almost identical to those of the corresponding non-recombinant counterparts, 
and self-assembled into native-type fibrils at predefined conditions (Myllyharju et al. 2000; 
Nokelainen et al. 2001). Although C-propeptides (~ 250 amino acids) are considered to be 
essential for correct triple helix structure assembly, substitution of C-propeptide with a short 
bacterial peptide ( a 29 amino acid sequence) not only led to more effective assembly of 
triple- helical structure in human type I and III collagen molecules, but also resulted in higher 
expression level (Pakkanen et al. 2003). The significance of the finding suggests the 
expression system could be engineered to develop correctly processed recombinant collagens  
for high-level production.  
By cloning or expressing part of the collagen gene, recombinant gelatins with well-
defined molecular weights and pIs could be produced to match specific requirements or 
applications. Accumulation levels up to 14 g/L of secreted gelatin have been reported in 
Pichia fermentations (Werten et al. 1999). These collagen-related proteins have been 
produced with consistent quality and used successfully for many applications. Studies using a 
series of Pichia-derived recombinant human type I collagen α1 chain fragments ranging in 
size from 56 to 1014 amino acids indicated that these recombinant collagen fragments can 
replace animal-derived gelatin on many current medical applications (Olsen et al. 2003). In 
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addition, a low molecular weight 8.5 kDa Pichia derived gelatin (pI 9.4) was shown to be 
equivalent to animal-derived gelatin as a stabilizer of an influenza virus vaccine with good 
lot-to-lot reproducibility and low allergenic potential (Baez et al. 2005). One challenge to 
producing recombinant gelatins via Pichia fermentation is the high susceptibility of the 
gelatins to proteolysis due to their open unfolded structure. The proteolytic degradation could 
be minimized but not eliminated by running the fermentation at pH 3 (Baez et al. 2005; 
Werten et al. 1999). A custom-designed, highly hydrophilic recombinant gelatin, however, 
has been shown to be fully intact by SDS-PAGE, N-terminal sequencing, gel filtration 
chromatography and mass spectrometry (Werten et al. 2001), suggesting recombinant 
gelatins could be produced as intended. Since the structure is not a requirement in 
recombinant gelatins, no co-expression of P4H is needed and the generated gelatins were not 
hydroxylated (Werten et al. 2001). Unlike the collagens, the recombinant gelatins can be 
secreted into the extracellular medium by introduction of a heterologous signal sequence 
such as the S. cerevisiae α-mating factor pre-pro sequence (Baez et al. 2005; Pakkanen et al. 
2006; Werten et al. 1999; Werten et al. 2001). Secretion eliminates the need of cell lysis by 
physical disruption and reduces the downstream process burden.  
 
Transgenic Plant-derived Recombinant Collagens and Gelatins  
Transgenic tobacco has been investigated as a cost-effective host to produce 
recombinant collagens. Although the plant has an endogenous P4H, the enzyme has different 
substrate specificity than the mammalian counterpart and the plant is thus unable to correctly 
hydroxylate recombinant human collagens. The human type I collagen accumulating in 
tobacco without cloned animal P4H shows that the content of hydroxylated proline is at a 
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negligible level (Ruggiero et al. 2000). The non-hydroxylated collagen, however, is able to 
correctly fold and form a triple-helical structure but at much slower propagation rate, 
compared with hydroxylated bovine type I collagen. Due to the lack of hydroxylation, the 
tobacco-derived collagen exhibits increased flexibility and reduced thermal stability. The 
latter is reflected in its reduced Tm, 30.5oC, which represents a more than 10oC decrease in 
temperature compared to 42oC for the native bovine Type I collagen. Moreover, the lack of 
hydroxylation prevents self-assembly into fibrils in the physiological buffer conditions where 
the corresponding non-recombinant bovine collagens do self-assemble. The phenomenon 
further emphasizes the unquestionably critical role of proline hydroxylation in stabilizing the 
collagen structure (Perret et al. 2001; Ruggiero et al. 2000).  
As in P. pastoris, co-expression of human collagen with heterologous P4H is 
necessary in the transgenic tobacco if hydroxylated recombinant collagens are intended 
(Merle et al. 2002). Recombinant hydroxylated human type I collagen has been successfully 
produced from transgenic tobacco by the co-expression of a cloned animal P4H enzyme. The 
tobacco-derived collagen has a hydroxyproline content of 8.4%, a little bit lower than the 
10% in Pichia pastoris- derived collagens and native collagens. In addition, the collagen 
adopts the expected triple-helical conformation, and has a Tm of 37oC, which is several 
degrees lower than that of the native bovine collagen, and much higher than the 30.5oC for 
the tobacco-derived non-hydroxylated collagens. The differences in the hydroxyproline 
content may explain the disparity in the Tm (Merle et al. 2002). 
Both non-hydroxylated and hydroxylated recombinant collagens undergo 
spontaneous processing from procollagens to mature collagens by the endogenous tobacco 
proteases during extraction and purification, thus eliminating the conversion of procollagen 
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by using pepsin digestion, as employed in the production of Pichia pastoris-derived 
collagens (Merle et al. 2002; Ruggiero et al. 2000). The result demonstrates a potential 
advantage of plants for the large-scale, low-cost production of collagens. Besides transgenic 
tobacco, recent studies indicated that transient and stable expression of human type I collagen 
can be achieved in barley and rice suspension cell culture (Dodge et al. 2006; Holkeri et al. 
2005) and in barley seeds (Ritala et al. 2007). 
 
Transgenic Plants for Recombinant Protein Production 
Since the first report of successful transformation of plants in 1983 (Fraley et al. 
1983), significant advances have been made in plant biotechnology to move plant-derived 
recombinant proteins from laboratory research to market. To date, three research-grade 
recombinant proteins have already been on the market: avidin, β-glucuronidase, and trypsin, 
all developed by ProdiGene Inc. from transgenic corn (Horn et al. 2004b). Although no 
recombinant plant-derived pharmaceutical protein for human use has yet reached the market, 
more than ten plant-derived proteins, such as gastric lipase and lactoferrin produced in maize 
by Meristem Therapeutics (Clermont Ferrand, France), were at one time in clinical trials (Ma 
et al. 2005; Sparrow et al. 2007). In January 2006 the first registration for a tobacco-derived 
poultry vaccine was granted to Dow AgroSciences (Indianapolis, IN) by the USDA, with the 
expectation of the first recombinant product for human use entering the market by 2009 
(Sparrow et al. 2007). Several recent reviews describe the merits of using plant hosts and 
possible expression strategies for the production of bioindustrial or biopharmaceutical 
recombinant proteins (Boehm 2007; Ma et al. 2003; Menkhaus et al. 2004a; Sparrow et al. 
2007; Twyman et al. 2003). 
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Transgenic plants offer several advantages over other recombinant systems. They are 
considered to be much safer than both microbe and animal expression systems because they 
generally lack human pathogens, oncogenic DNA sequences, and endotoxins. Another major 
advantage of transgenic plants is the potential for lower capital investment and production 
cost, and the latter was thought to be less than 15% of that required for mammalian cell 
culture (Menkhaus et al. 2004a).  In addition, recombinant plant systems are easy to scale up: 
production volumes can be increased by increasing planted acreage (Howard and Hood 2005). 
If recombinant proteins are targeted for expression in seeds, the transgenic plants are 
particularly attractive in that they can accumulate the proteins in a small volume and provide 
a stable storage environment. Seed may be stored without loss of protein activity for at least 
six months (Bai and Nikolov 2001; Stoger et al. 2000) or more than a year in some cases 
(Kusnadi et al. 1998). The existence of well-established infrastructure for cultivating, 
harvesting, transporting, and storing plant matter also contributes to low production cost. In 
general, the low cost of growing a large amount of biomass, ease of scale-up (increase of 
planted acreage), capability of long term storage, and established practices for efficient 
processing of the plant make transgenic plant systems an ideal option for industrial 
recombinant protein production. However, regulatory issues have offset these technical and 
economic advantages, stalling implementation of plant-made proteins. The risk of 
contamining the feed and food chain with transgenic food crops, such as rice, barley, maize 
and soybean, is currently not acceptable whether or not the recombinant protein poses any 
actual health risk. Prevention of contamination must be addressed by temporal and spatial 
segregation measures to control cross-pollination with other crops during flowering cycles 
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and elimination of seed spillage and seed mixing during transportation and handling in order 
to allay those regulatory concerns (Sparrow et al. 2007). 
 
Protein Localization in Plant Cells 
Previously we mentioned that one major advantage of transgenic plants as bioreactors 
is the low capital and running costs. Since the expression level directly affects the cost of 
cultivation, extraction, purification and waste disposal, and consequently, the feasibility of 
commercialization, the economic advantages of plant production systems cannot be realized 
unless the recombinant proteins can be produced at high yields. It is estimated that the 
expression level needs to be at least 0.1% of biomass weight (e.g. 1 g recombinant protein/ 1 
kg of seeds) for plants to remain competitive in cost (Nandi et al. 2005). One of the most 
important factors governing the yields of recombinant proteins is the protein localization in 
plant cells because the subcellular compartments where recombinant proteins accumulate 
strongly influence the interrelated processes of folding, assembly and post-translational 
modification. All of those contribute to protein stability and thus determine the final yields 
(Fischer et al. 2004). 
A tissue-specific promoter (e.g. embryo-specific, endosperm-specific) can be chosen 
that allows a particular tissue, such as germ or endosperm of corn seeds, to accumulate a 
particular recombinant protein. In addition to the promoter, a signal sequence fused to the 
expression construct can target the protein to a subcellular compartment within that tissue to 
maximize that promoter’s work. If a signal sequence is present, the newly synthesized 
proteins are transported to the ER. From there, the proteins are directed to the subcellular 
compartments such as Golgi apparatus, cell wall, vacuole, and plasma membrane. Proteins 
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can also be retained in the ER, like the recombinant human type I collagen expressed in the 
transgenic tobacco (Merle et al. 2002; Ruggiero et al. 2000). In the absence of a signal 
sequence, the recombinant protein will accumulate in the cytoplasm (Hood 2004; Streatfield 
2007). 
In a study to achieve high-level expression of a recombinant fungal laccase in 
transgenic maize, combinations of three distinct promoters (constitutive, embryo-specific, 
and endosperm-specific) and four targeting sites (cell walls, ER, vacuole, and cytoplasm) 
were tested to determine best locations for high-level accumulation of the protein. The 
embryo (germ)-specific expression with the protein being targeted to the cell wall resulted in 
highest expression level (Hood et al. 2003). The same technology was applied to the 
expression of a sweet protein brazzein, and achieved a high expression level-4% of the total 
soluble protein in maize seed (Lamphear et al. 2005).  
Other experiments have shown that recombinant antibodies targeted to the subcellular 
compartments through the ER or retained in the ER usually accumulate to levels that are 
several orders-of-magnitude greater than those of antibodies expressed in the cytosol 
(Schillberg et al. 2003; Twyman et al. 2003). The reason is that many important post-
translational processing elements like chaperones, protein-disulfide isomerase, and 
glycosylation enzymes are present in the ER but not at all or scarcely present in the cytosol. 
Those elements are required for correct protein folding and assembly. Without them, the 
proteins do not assemble into the mature structure and consequently degrade, resulting in  
low final yields (Boehm 2007). Protein storage vacuoles, a post-Golgi compartment, are also 
reported to be good destinations as stable protein accumulation is facilitated (Stoger et al. 
2005). A recombinant enzyme (1, 3–1, 4)-β-glucanase) accumulates at a high level in 
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transgenic barley storage vacuoles of the mature grain endosperm (Horvath et al. 2000).  All 
those results have demonstrated that optimizing transformation and cell lines to target to 
different subcellular localization might consistently elevate the expression levels to those of 
microbial or animal-based systems.   
Targeting of recombinant proteins to subcellular compartments, such as oil bodies or 
the plasma membrane, not only increases expression level as described previously, but 
facilitates isolation and purification as well. One example is the oleosin-fusion platform 
developed by SemBioSys Genetics (http://www.sembiosys.com, Calgary, Canada), in which 
the target recombinant hirudin was fused with oleosin. The oleosin-hirudin fusion protein 
was correctly targeted to the oil body membrane and separated from the majority of other 
seed proteins by flotation centrifugation. The recombinant hirudin was released from its 
fusion partner by endoprotease digestion (Parmenter et al. 1995). Another example is an anti-
viral antibody fragment fusion protein which accumulated at the plasma membrane and could 
be extracted in a small volume by proper buffers and detergents (Schillberg et al. 2000). 
Similar to targeting recombinant proteins to subcellular compartments, using tissue-
specific promoters to target proteins to a specific part or tissue that can be easily separated 
from the rest of the plant material before protein extraction would not only result in higher 
purity extract, but also facilitate the downstream process and reduce the processing cost. For 
example, maize germ (embryo) is considered well suited for the expression of some 
recombinant proteins at high levels, as demonstrated by the expression of a recombinant β-
glucuronidase (Witcher et al. 1998) , avidin (Hood et al. 1997), fungal laccase (Hood et al. 
2003), bovine trypsin (Woodard et al. 2003), brazzein (Lamphear et al. 2005), and bovine 
aprotinin (Zhong et al. 2007). Since the germ makes up about 12% of the whole maize kernel, 
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a germ-rich fraction generated by the dry-milling process can result in a 5-10 fold enrichment 
of the recombinant protein content, as well as a 5-10 fold reduction of biomass compared to 
the whole grain. As the cost of processing is inversely proportional to the concentration of 
the product protein in the starting materials and the reduced biomass leads to the decrease in 
extract volume, the fractionation of seeds by dry milling can greatly reduce the cost. In 
addition, the 90% of non-germ fraction (basically endosperm and hulls) can be utilized for 
other applications such as ethanol or adhesive production, and domestic animal feed. 
Therefore, the cost of the recombinant protein could be further reduced by the byproduct 
credits (Howard and Hood 2005).  
 
Post-translational Modification  
The protein synthesis pathway is conserved between plants and animals so plants 
appear to efficiently fold and assemble recombinant human proteins. This is a great 
advantage since proteins failing to fold properly will be degraded, resulting in low yields. 
The ability of plants to fold and assemble complex proteins correctly is demonstrated by their 
capacity to produce functional serum antibodies and secretory antibodies (Twyman et al. 
2003).  However, there are some differences in posttranslational modifications. As discussed 
before, transgenic tobacco is unable to correctly modify/hydroxylate recombinant human 
collagens unless a heterologous P4H is co-expressed (Merle et al. 2002). Another difference 
is glycosylation.  First, plant glycosylation patterns and extents differ from those of animals 
(Giddings et al. 2000). Plants might add plant-unique sugar groups to or alter the sugar 
moieties on the recombinant proteins during the post-translational processing. A maize-
derived bovine trypsin was unexpectedly glycosylated, while the native bovine trypsin did 
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not have glycosylation. But the difference did not prevent the protein from functioning 
equivalently to its native counterpart (Woodard et al. 2003). The β1,2-xylose and α1,3-fucose 
of plant origin were found to replace the galactose and sialic acid in the maize-derived 
human lactoferrin (Samyn-Petit et al. 2001), and a similar case was reported for rice-derived 
human lactoferrin (Nandi et al. 2005). Although the unintended addition and alteration of 
carbohydrate groups in plants represents potential allergen or antigen sources, no cases of 
allergenic or immune responses have been reported to date (Horn et al. 2004b; Howard and 
Hood 2005). Another glycosylation difference between plant and mammalian systems is that 
the former cannot produce sialic acid for inclusion in the glycoprotein (Howard 2005). 
Addition of the sialic acid is thought to be responsible for the extended clearance time of the 
glycoproteins in the blood stream. Consequently the difference might limit the potential of 
the transgenic plants to produce some recombinant human proteins (Howard 2005).    
 
Corn as Host for Recombinant Protein Production: 
Corn or maize (Zea Mays L) is the most important crop in the United States and one 
of the most important crops in the world. Corn is widely distributed throughout the world and 
accepted as a safe product as food, feed, and raw material for industrial applications. The 
protein content of the corn varies depending on type, variety, and other factors, ranging from 
6-18% in the kernel. The proteins can be divided into four categories according to the 
Osborne classification, which is based on the solubility of the proteins in various solvents. 
The Osborne classification scheme is as follows (adapted from (Johnson 2000; Lawton and 
Wilson 2003). 
Albumins: soluble in pure water (salt-free)  
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Globulins: soluble in dilute salt solutions, but insoluble in pure water 
Prolamins: soluble in non-polar solvents, e.g. 70% ethanol 
Glutelins: soluble in dilute acid or base w/o a small amount of reducing agent 
The corn kernel can be separated either into chemical constituents (starch, 
gluten/protein, fiber, germ/oil) or anatomical parts (endosperm, germ and bran), depending 
on different objectives. The endosperm accounts for more than 80% of the whole corn kernel 
on dry weight basis, and contains the majority of the starch. Although endosperm has an 
average protein content of only 8-9%, it contains about 75% of total proteins in the corn due 
to its large volume. The germ makes up about 11% of the whole corn kernel, contains most 
of the oil, and has the greatest protein concentration (17 to 20%). The bran accounts for 5% 
of the whole corn kernel and is mainly composed of fiber (Johnson 2000). A detailed 
distribution in each fraction is shown in Table 1. 
Corn (or maize) has been the most widely used plant host for the production of 
recombinant proteins. In addition to the advantages possessed by all plant production systems, 
such as low cost of growing biomass, the convenience of scale-up, well-established practices 
and infrastructure for efficient harvesting, transporting, storing and processing, it provides 
extra benefits of stable long-term storage encased seed with little or no microbial burden, 
well-developed transformation technology and ease of in vitro manipulation (Ma et al. 2003; 
Ramessar et al. 2008; Sparrow et al. 2007; Twyman et al. 2003). Those are among the major 
factors that prompted Prodigene Inc. to choose corn as the first plant for the commercial 
production of three recombinant proteins-avidin, β-glucuronidase, and trypsin (Horn et al. 
2004b). In 2005, Meristem Therapeutics was granted authorization to use corn for field 
production of mammalian gastric lipase for the treatment of lipid malabsorption related to  
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Table 1. A typical composition in the anatomical components (adapted from (Johnson 2000). 
 
exocrine pancreatic insufficiency and monoclonal antibodies for the treatment of various 
types of cancer (www.meristem-therapeutics.com). Other corn-derived recombinant proteins 
developed within the past several years include aprotinin (Azzoni et al. 2002; Zhong et al. 
1999), laccase (Bailey et al. 2004; Hood et al. 2003), brazzein (Lamphear et al. 2005), human 
lactoferrin (Samyn-Petit et al. 2001), human proinsulin (Farinas et al. 2005b), cellulase 
(Hood et al. 2007), antibodies (Hood et al. 2002) and vaccines (Horn et al. 2004a; Lamphear 
et al. 2004; Lamphear et al. 2002; Streatfield et al. 2003). The main disadvantages of corn are 
its open pollination and wide planting for food and feed.  Appropriate confinement measures 
are necessary to prevent the risk of cross-pollination or seed mixing with other corn crops. 
Planting location and timing can avoid cross-pollination with other corn planting (Ramessar 
et al. 2008). Until such practices become accepted, lemsa, rice, and barley will continue to be 
examined as alternatives that have less risk of cross-pollination.  
 
Downstream Processing of Recombinant Proteins Produced in Plants 
Downstream processing of recombinant proteins produced in plants usually consists 
of plant tissue fractionation, protein extraction and protein purification (Menkhaus et al. 
Component Protein, % Fat, % Starch, % Fiber, % Other, % 
Endosperm 8.0 0.8 87.6 3.2 0.4 
Germ 18.4 33.2 8.0 14.0 26.4 
Bran 3.7 1.0 7.3 83.6 4.4 
Whole kernel 8.7 4.1 71.3 3.0 1.5 
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2004a). It is estimated that the cost of downstream processing accounts for more than 80% of 
production cost (Evangelista et al. 1998). Therefore, development and optimization of 
downstream processing methods is necessary to reduce cost, which, in combination with 
expression level, might govern the economic feasibility of transgenic plant systems.    
 
Plant Tissue Fractionation 
Since transgenic corn seeds were used in our research, the following discussion 
mainly focuses on corn seeds. The main purpose of fractionation is to reduce the biomass for 
the protein extraction. Dry milling is able to separate the corn kernel into three anatomical 
fractions: germ, endosperm, and hulls. In dry milling the corn kernels are moisture-
conditioned, dehulled, degermed, roller milled and fractionated through a series of sieves and 
aspirators (Yildirim et al. 2002). Fractionation by dry milling has a significant impact on 
downstream processing.  For example, if the desired protein is targeted to germ, the dry-
milling process can generate a germ-rich fraction with a 5- to 10- fold enrichment of the 
protein content compared to the whole grain (Howard and Hood 2005). In addition, the 
biomass required to produce the desired protein is reduced 5-to 10- fold which not only 
greatly lowers the extraction cost, but also cuts down the cost of waste disposal. But the high 
oil content of the germ-rich fraction could interfere with protein purification; therefore, 
defatting /deoiling may be necessary before protein extraction and purification. In addition, 
germ represents a more complex matrix for protein accumulation than endosperm, which 
could make the separation of target proteins from host corn proteins more difficult. On the 
other hand, if the target is the endosperm-rich fraction, a neutral salt buffer would leave 
nearly 80% of native corn proteins in the residual endosperm solids rather than in the extract, 
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thus considerably simplifying the later purification process (Menkhaus et al. 2004a). Wet 
milling, which can separate the corn kernel into a great number of components more cleanly, 
has not been studied extensively for the downstream processing of recombinant proteins.   
 
Protein Extraction 
Protein extraction is carried out by adding ground corn (either germ-rich or 
endosperm-rich fraction) to aqueous buffers, where the proteins are released from the plant 
cells to the aqueous medium. The choices of the extraction medium and conditions, such as 
buffers, ionic strength, pH, ratio of the extraction buffer to the plant tissues, extraction time 
etc., are important to achieve satisfactory recovery of the recombinant proteins while 
minimizing the amount of the native proteins extracted, and thus reducing the cost of the later 
purification processing.  
Of all the extraction parameters, pH and ionic strength have the greatest effects on the 
protein extraction efficiency, and have been most extensively studied. The total extractable 
corn endogenous protein concentration increased about 10-fold by increasing the pH from 3 
to 10 (Azzoni et al. 2002; Zhong et al. 2007). A similar trend in pH was reported in 
extracting a recombinant human proinsulin from transgenic maize endosperm (Farinas et al. 
2005b).  Ionic strength has less significant effect than pH, but the total extractable corn 
endogenous protein concentration also increases with addition of NaCl up to 300 mM 
(Azzoni et al. 2002). The effects of pH and ionic strength on the recombinant protein 
extracted from the corn seeds vary, and the optimal extraction conditions should be 
determined on case-by-case basis. However, as a rule of thumb, to reduce the protein 
complexity of the extract and simplify the purification process, acidic pH condition is desired, 
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as long as the recombinant proteins can be solubilized under acidic conditions. In addition, 
the acidic pH results in less extraction of other corn metabolites, such as carbohydrates and 
phenolic compounds, which are considered to interfere with chromatography (Farinas et al. 
2005a). Since gelatins and collagens are acid soluble (Ruggiero et al. 2000), the above rule 
can apply here, and acidic pHs will help reduce the crude extract complexity. 
The buffers used to maintain the pH during the extraction process necessarily change 
with the choice of pH.  Commonly used extraction buffers include glycine, sodium acetate, 
sodium phosphate, potassium phosphate, Tris and sodium carbonate with concentrations of 
50 mM or below; hence, the contribution to ionic strength is low.  There is no report that the 
buffer salt influences extraction separately from the pH and ionic strength contributions.  The 
ratio of the ground corn seeds to buffers is usually 1:5, or sometimes 1:10, and extraction 
time needs to be determined empirically, depending on the specific recombinant proteins. 
Some recombinant proteins may be susceptible to proteolytic degradation due to the 
concomitant release of the endogenous proteases during the protein extraction. The addition 
of protease inhibitors or lowering pH could mitigate the degradation (Werten et al. 1999).     
 
Protein Purification: 
As with the purification of recombinant proteins produced from other expression 
systems, no generic procedure is available for purifying a recombinant protein produced from 
transgenic corn or other plants. A body of knowledge must be built to purify a particular 
recombinant protein, and it is different for each protein. Therefore, a purification process 
needs to be designed according to the specific target protein, however, there are still some 
general rules that can be followed. Purification can generally be divided into three steps 
  
24
 
(Figure 2): a capture step, where proteins are partially enriched and purified; all intermediate 
step, where a majority of contaminant proteins are removed, resulting in a purity of 60-80%; 
and a polishing step, where trace amounts of contaminant proteins are removed, leading to 
purities up to 100%. However, there are no definite lines between the steps, and purification 
can be achieved with two steps or even one step. The number of steps used will always 
depend upon the purity requirements and intended use for the protein. 
 
Chromatography 
Chromatography is ubiquitous in protein separations and considered as a very 
important part of almost any purification strategy due to its high resolution. Chromatography 
commonly used for each step and the mechanism for each chromatographic method are 
summarized in Table 2.   
(Note to Reader: The following detailed discussion of each chromatographic method 
is based on my personal understanding and lab experience and is intended for future students. 
Other readers may want to proceed to the next section on the “Overall Process”.)  
Affinity chromatography (AC) makes use of highly specific molecular recognition. It 
has the highest specificity and selectivity of all chromatographic methods, and is the most 
efficient method especially for target proteins at low concentration in the starting materials. 
For immunoglobulin (e.g. IgGs), commercially available affinity resins, such as Protein A or 
Protein G, are ready and easy for use. While for non-immunoglobulin recombinant proteins, 
a preparation of antibodies for the target proteins (viewed as antigen) is necessary. The best 
way to obtain the antibodies is by immunizing animals (e.g. mouse, rabbit, and goat) by 
injecting the product protein purified by other techniques, such as chromatography. 
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Figure 2. Three step purification strategy 
 
 
Table 2. Separation technologies in the design of a downstream process (adapted from 
Protein Purification Handbook (18-1132-29), Amersham Biosciences) 
Chromatography Protein property Capture Intermediate Polishing 
AC  
(Affinity Chromatography) Biospecificity √ √ √ √ √ √ √  
IEX 
(Ion Exchange) Charge √ √ √ √ √ √ √ √ √ 
HIC  
(Hydrophobic Interaction 
Chromatography) 
Hydrophobicity √ √  √ √ √ √  
SEC  
(Size Exclusion 
Chromatography) 
Size  √  √ √ √ 
RPC 
(Reverse Phase 
Chromatography 
Hydrophobicity  √  √ √ √ 
 
(Note: more √ means more likely that chromatography can be used in that step) 
Increase 
Purity 
Number 
of steps 
Preparation (extraction, clarification) 
Capture step 
Intermediate step 
Polishing step 
Removal of bulk 
contaminants 
Enriched and 
partially purified 
Removal of trace 
contaminants 
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Commercially available antibodies generated from native proteins could be a convenient 
option, but it runs the risk that the proteins produced from recombinant systems might not 
recognize them. The antibodies then need to be immobilized (covalently attached) to a 
porous matrix, followed by packing into a chromatographic column.  One commonly used 
matrix is highly cross-linked agarose beads which usually have a size <100μm. Detailed 
information of immobilization methods could be found in an affinity chromatography 
handbook (Amersham Biosciences, 18-1022-29). Antibody binding to target proteins during 
chromatography is carried out at neutral pHs, and elution usually performed by using acidic 
pHs (< 4). Since the acidic pH would denature the proteins, eluted pools (containing target 
proteins) should be quickly neutralized with buffers like 2M Tris base (pH>9). Elution can 
also be conducted by increasing salt concentrations or introducing chaotropic agents (e.g. 
urea), but these eluents are less common than pH elution. A single step of affinity 
chromatography of the clarified corn extract resulted in a more than 90% pure corn-derived 
avidin with > 90% recovery (Kusnadi et al. 1998). In addition, affinity chromatography as a 
capture step separated a corn-derived aprotinin from the majority of host contaminating 
proteins, increasing its purity from 0.28 to 9.6% with a purification factor of 33 (Azzoni et al. 
2002). Without an affinity column, more chromatography steps would be needed to achieve 
the same purity.  
Ion-exchange (IEX) chromatography separates proteins primarily according to their 
overall charges. The principle of IEX is based on the competition between charged proteins 
and salt ions for the adsorbent sites. During sample loading, proteins displace salt ions and 
attach to the resin; at elution, the proteins are displaced by ions at much higher concentration, 
hence “ion exchange”. The net surface charge of proteins varies according to the surrounding 
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pH. When above its isoelectric point (pI at which a protein has a net charge of zero) a protein 
will bind to a cation-exchange (CEX) resin (e.g. carboxymethyl, sulphopropyl resin); when 
below its pI a protein will behind to an anion exchange (AEX) resin (e.g. diethylaminoethyl). 
So, the pI of the protein will determine what pH and resins can be used for the purification. 
For example, a recombinant gelatin with pI of 9.4 will be positively charged at pHs lower 
than its pI, which makes CEX chromatography a good choice (Olsen et al. 2005).  
IEX buffer is necessary to maintain the pH at which the chromatography is running. 
Correct choice of buffer can be crucial to success since the ionic interactions are highly 
dependent on pH and buffer species may take part in the ion exchange process. When 
choosing a buffer, several things need to be considered (Scopes 1994): 1) the pKa (the pH at 
which the ratio of conjugate base and acid forms is 1 and the buffer has maximum ability to 
resist changes in pH) of the buffer should be not more than 1 unit, and preferably 0.5 unit 
away from the working pH; 2) the buffer species should not interact with the resin, e.g. for 
AEX resin, choosing a positive buffering ion (Tris) and for a CEX resin, choosing a negative 
buffering ion (acetate, phosphate) ;3) the pH in the microenvironment of the resin matrix 
may be significantly different from that of applied buffer due to ion exchanging, so enough 
buffer species (at least > 20 mM) is required. Another important practical aspect is the actual 
column/resin capacity for the proteins being adsorbed. The adsorptive or binding capacity of 
IEX resins varies for individual proteins, highly dependent on properties such as protein size 
and chromatographic running conditions such as flow rate. So, a preliminary experiment to 
estimate dynamic binding capacity is usually needed. For optimal separations when 
performing gradient elution, it is advised to use approximately one-fifth to one-twentieth of 
the total binding capacity of the column (Scopes 1994). In general, IEX is the most 
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commonly used chromatography; it has high loading capacity-independent of volume and 
high resolving power. It concentrates target proteins which are generally stable in running 
conditions. It allows for versatile operation; optimal separation could be achieved by 
manipulating pH, buffers, and elution gradients. 
Both hydrophobic interaction chromatography (HIC) and reverse phase 
chromatography (RPC) separate proteins based on the reversible hydrophobic interaction 
between a protein and the surface of a chromatographic resin. The difference between the 
two chromatography is that RPC uses organic solvent (e.g. acetonitrile) to elute proteins, and 
it has high resolution and is more proper to separate small proteins or peptides for analytical 
purposes, while HIC uses aqueous solution for elution, and its goal is to purify proteins of 
interest for further analysis or investigation. Since the downstream process development is to 
prepare pure materials, the following discussion will focus on HIC.  
The hydrophobicities of target proteins influence the selection of hydrophobic resin 
which is usually made of linear aliphatic chains or aromatic groups. The longer the chain, the 
more hydrophobic the resin is.  
 Protein samples in most cases need to be in a high salt concentration that enhances 
the interaction in order for the target protein to bind, however, too high a salt concentration 
would start precipitating the protein. Therefore for the HIC development, an important goal 
is to find a buffer condition such that the ionic strength/salt concentration is high enough to 
promote adsorption, but not so high as to cause precipitation of the product protein. The most 
commonly used buffer at laboratory scale is ammonium sulfate, but sodium sulfate and 
sodium chloride are more common in industry because they cause less severe disposal 
problems. Usually simple batch adsorption tests are sufficient to determine the amount of 
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salts needed. Proteins are often eluted by decreasing the salt concentration. If the target 
protein binds strongly and does not elute even at low salt concentration, then it is worth 
considering a less hydrophobic resin. An alternative is adding organic solvent (e.g.  ethylene 
glycol gradient up to 50%), chaotropic species (urea, guanidine hydrochloride) or detergents 
to reduce eluent polarity (Protein Purification Handbook (18-1132-29), Amersham 
Biosciences). But this will increase the complexity of the eluted sample, and removal of 
those solutes can be a nuisance.  
Since HIC loads sample with high salt and separates proteins by the mechanism 
complementary to IEX, a natural and convenient two-step chromatographic process could be 
to start with an IEX column followed by HIC (Lightfoot and Moscariello 2004). The IEX 
column can directly bind proteins from the feed stream, and the higher salt needed for elution 
is helpful for adsorption on the HIC column. In general, HIC does not usually have as sharp 
separation as IEX, but it has similarly high loading capacity. It does not need buffer 
exchanging or pH adjustment, but adding sufficient salt to ensure binding before sample 
application is necessary. 
Size exclusion chromatography (SEC) separates proteins according to their size, 
which is closely related to their MWs. When applied to the separation of biomolecules in 
aqueous solutions, it is referred to as gel filtration chromatography (GFC). The development 
of SEC process is straightforward. No buffer adjustment of sample from previous steps is 
needed for sample application. Buffer conditions are chosen to meet the requirements for 
further purification, analysis or storage, as buffer composition does not directly affect 
resolution. Up to 0.15 M NaCl can be added to aqueous buffers to avoid non-specific ionic 
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interaction of proteins with the column matrix. Proteins are collected in purified form in the 
chosen buffer (Gel filtration: principles and methods (18-1022-18), Amersham Biosciences).  
However, there are some weaknesss of SEC that limit its use at large scale. Applied 
sample volume is very low, up to 4% of total column volume to achieve good resolution, 
which in turn requires a relatively large amount of chromatographic resin. The follow rate is 
low, usually < 0.5 cm/min, leading to prolonged process time for a large column. In general, 
SEC is ideal for the final polishing step on bench scale when sample volumes are greatly 
reduced. It is a very gentle method, and often gives near 100% recovery (Scopes 1994). In 
addition, the SEC process is easy to develop and operate. 
 
Overall Process 
Purification of recombinant proteins from transgenic plants is usually composed of a 
combination of the above discussed chromatographic methods. Two chromatographic steps 
(affinity followed by CEX chromatography) produced a corn-derived aprotinin with high 
purity (single SDS-PAGE band) and about 40% yield (Azzoni et al. 2005). Purification of the 
corn-derived aprotinin was also tried by a non-affinity process, which started with CEX 
followed by HIC. The results demonstrated that the combination of CEX and HIC was a 
promising alternative to affinity chromatography for purifying recombinant aprotinin from 
the germ fraction of transgenic corn seeds (Zhong et al. 2007). More generic processes 
composed of multi-step chromatographic columns were used to purify several other proteins. 
A recombinant human lysozyme was purified to a single SDS-PAGE band with 60% 
recovery from a high-expression transgenic rice line by a combination of CEX and SEC 
(Huang et al. 2002). In some cases, more than three chromatographic steps were required to 
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achieve satisfying purity, especially when the target protein purity was very low in the 
starting material. A four- step chromatography procedure (AEX I, HIC, AEX II, SEC) was 
reported to yield 90% plus pure β-glucuronidase from corn extract with 27% recovery 
(Kusnadi et al. 1998). Coming with more chromatographic steps are decreasing yield and 
increasing cost, which further emphasizes the importance of extraction optimization and 
pretreatment (e.g. plant tissue fractionation) to reduce the complexity of the crude sample 
solution.  
 
Non-chromatographic Methods 
Although chromatography has been the workhorse for purifying high-value 
recombinant pharmaceutical proteins, such as monoclonal antibodies, the high cost and 
limited throughput associated with chromatography prompted the development of new or 
alternative technologies for large-scale recombinant protein production (Przybycien et al. 
2004; Thommes and Etzel 2007). The traditional, inexpensive, non-adsorptive method of 
precipitation is one promising alternative, especially for the production of low-valued 
proteins as byproducts from less-expensive raw materials, such as plants. In addition, 
precipitation can be complementary to adsorptive chromatography in terms of separation 
mechanism.  
Many precipitation methods including heat, organic solvent, salt, isoelectric, and 
polyelectrolyte precipitation have been evaluated as early purification steps. Heating the corn 
extract was reported to remove a fraction of native corn proteins from corn extract (Zhong et 
al. 2007), but would not be useful for heat-labile products. Organic precipitants, such as 
acetone and ethanol, have been used to recover recombinant gelatin produced from yeast P. 
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pastoris (Werten et al. 1999; Werten et al. 2001) and H. polymorpha (de Bruin et al. 2002). 
Like heating, addition of organic solvents has a tendency to denature proteins, which makes 
it less commonly used. Salts are commonly used to precipitate proteins, and ammonium 
sulfate and sodium chloride have been successfully applied to recombinant gelatin or 
collagen expressed in yeasts and plants (Baez et al. 2005; Nokelainen et al. 2001; Perret et al. 
2001; Werten et al. 2001). Isoelectric precipitation from canola resulted in a 3-fold 
enrichment of lysozyme (Zaman et al. 1999), and from pea showed a 4-fold enrichment of β-
glucuronidase with 80% yield (Menkhaus et al. 2004b). Polyelectrolyte precipitation with 
PEI, a polycationic precipitating agent, showed different level of success: GUS precipitated 
from pea achieved 18-fold enrichment, whereas GUS from corn only resulted in a 
purification factor of 2.6 (Menkhaus et al. 2002). In addition, polyelectrolyte precipitation of 
lysozyme from canola gave a poor performance. A disadvantage of using polyelectrolyte is 
that it is not easily removed from precipitated complex.  In general, the efficacy of 
precipitation methods varies greatly, and depends highly on the composition of the protein 
mixture.  
 
Cost-effective Process Development for Recombinant Collagen Purification 
Compared to other high-valued recombinant proteins such as antibodies, recombinant 
gelatins and collagens are usually used as supplementary ingredients. So for the sole purpose 
of their purification, relatively low purity is acceptable (>80%) and cost-effective purification 
methods are critical to make them competitive with their native counterparts. Literature has 
shown that salt precipitation alone is able to achieve high purity for plant or Pichia-derived 
gelatins or collagens. A tobacco-derived recombinant collagen with an estimated 
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concentration of 0.02 mg/ml in tobacco extract was purified to 90% by 0.9 M sodium 
chloride (NaCl) precipitation (Ruggiero et al. 2000). Another example was the use of 
differential ammonium sulfate precipitation to obtain a gelatin with an estimated purity of > 
98% (Werten et al. 2001). In addition, Baez et al. (2005) reported that a precipitation 
protocol including three salt precipitations at different pHs resulted in highly purified Pichia-
derived collagens.  These results suggest that gelatins or collagens are sensitive to salt 
precipitation, and this information might help us to establish a similar precipitation method 
for the cost-effective production of corn-derived gelatins or collagens.  
 
Protein Characterization 
 
Characterization of recombinant proteins from plant hosts is needed to assess 
accuracy of the expression system.  SDS-PAGE still remains a useful tool to check the purity 
and MW of the product protein. With the help of the specific immuno-reaction between 
antibody and antigen, Western blotting, a tool complementary to SDS-PAGE, is able to 
confirm the existence of the target protein and detect the isoforms or fragments of the protein. 
While SDS-PAGE can only estimate a protein’s mass, MS (mass spectrometry) is able to 
measure mass with high accuracy, which provides supplemental evidence that the target 
protein is correctly expressed. Since the inaccuracy of MS is proportional to the size of the 
molecule, proteins with relatively high MW (e.g. > 50 kDa) might not allow the MS to pick 
up the mass difference between the measured protein mass and theoretical mass and attribute 
that difference to any specific modification.  In order to better identify the protein, tandem 
MS (MS-MS) can be implemented to deduce internal peptide sequence. The extent to which 
the MS data represents the protein sequence is referred to as “coverage”. Literature use of 
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MS to verify that a protein is being expressed relies on as little as 10-15% sequence coverage 
on the basis of the low probability of another protein containing the same combination of 
peptides (Liebler 2002). Higher sequence coverage is needed if we would like to detect 
protein modification on amino acids.  N-terminal sequencing would provide more evidence 
to identify the protein and common N-terminal modifications.  
Previous studies of plant-derived recombinant proteins have focused more on the 
production and downstream processing.  Limited protein characterization such as SDS-
PAGE and N-terminal sequencing was provided for aprotinin (Azzoni et al. 2002), β-
glucuronidase, and avidin (Kusnadi et al. 1998) for assessing the accuracy of expression and 
product stability. More characterization, including Western blotting, MS, and glycosylation 
staining, was implemented for a corn-derived bovine trypsin (Woodard et al. 2003) to better 
analyze the product. The differences in molecular weight between corn seed-derived and 
native trypsin were determined to be due to O-linked glycosylation on the corn-derived 
protein demonstrated by the chemical glycosylation removal resulting in the proteins having 
the same apparent molecular weight. Glycoprotein staining can be used to detect the presence 
of glycosylation. However, detailed information about the glycan groups, and at what amino 
acids modification takes place requires combination of advanced analytical techniques such 
as HPLC and MS, and the discussion of that is beyond the scope of this review. Karnoup et al. 
(2005) showed that O-linked glycosylation found in a corn-derived human IgA took place 
through hydroxylated proline residues, indicating that plant was able to convert proline to 
hydroxyproline. Amino acid analysis is a convenient method to determine how much proline 
is hydroxylated, as long as the protein is pure and a hydroxyproline standard is available.   
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Purification of Recombinant Gelatins or Collagens for Characterization 
For the purpose of characterizing recombinant gelatins or collagens from Pichia or 
tobacco, a general approach to prepare a pure sample  is a combination of precipitation 
method plus a single step of chromatography such as ion exchange (Olsen et al. 2001; Perret 
et al. 2001) or gel filtration chromatography (Myllyharju et al. 2000; Nokelainen et al. 2001). 
Some characterization such as amino acid analysis needs ultrapure preparation, so one more 
step of high resolution chromatography such as reverse-phase chromatography (Baez et al. 
2005; Perret et al. 2001; Ruggiero et al. 2000) or affinity chromatography (Vuorela et al. 
1997) is commonly used. A possible alternative to separate minor amounts of impurities is 
SDS-PAGE, which is nicely compatible with analytic methods such as MS and N-terminal 
sequencing. 
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CHAPTER 2. PURIFICATION AND CHARACTERIZATION OF 
A 44 kDa RECOMBINANT COLLAGEN I alpha 1 FRAGMENT 
FROM CORN SEED  
 
A paper to be submitted to Journal of Agricultural and Food Chemistry  
Cheng Zhang1, Julio Baez2, and Charles E. Glatz3 
 
Abstract 
Corn grain is currently used as feedstock for the production of many industrial 
products. If recombinant proteins with equivalency to proteins currently obtained from other 
sources could be produced in corn hosts as a co-product, there is great potential for lowering 
the cost of production of the protein. While several recombinant proteins have been produced 
in corn, the extent of their characterization has been limited and their compatibility with 
biorefinery production is poor.  We have purified and characterized a potentially suitable co-
product, a 44 kDa fragment of human collagen I alpha 1 (CIα1). The 44 kDa CIα1 fragment 
was selectively extracted from ground grain at low pH and purified with the additional steps 
of ion-exchange and gel filtration chromatography, resulting in 44 kDa CIα1 with >70% 
purity and 60% yield. The N-terminal sequence, amino acid composition and 
immunoreactivity of the purified corn grain-derived 44 kDa CIα1 closely matched that of an 
analogous 44 kDa CIα1 fragment produced by the yeast Pichia. The corn-derived 44 kDa 
CIα1fragment had an intact protein mass of 44,088 Da that is within 0.2% of the mass 
                                                 
1 Primary researcher and author, responsible for purification process development and protein characterization   
2 Co-author, supplying information and materials on collagen/gelatin assays and chemistry   
3 Author for correspondence 
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calculated from the expected sequence. Tandem mass spectrometry confirmed the primary 
sequence of the corn grain-derived 44 kDa CIα1 with 78% coverage. The amino acid 
composition analysis indicated a low level of prolyl hydroxylation, as has been seen for other 
corn grain-derived recombinant proteins. Glycoprotein staining revealed no glycosylation. 
These results provided strong evidence that the corn grain-derived 44 kDa CIα1 fragment 
accumulated in corn grain with the intended composition and post-translational modifications.  
This is the first expression of a collagenous protein in a cereal seed.  
  
Key words: recombinant collagen fragment, gelatin, protein extraction, purification, 
characterization, chromatography, transgenic corn, maize.  
 
Introduction 
Though several safety and social concerns remain to be addressed, use of corn as an 
expression host has attractive potential for intermediate-value, recombinant protein-based 
products, particularly if the expression and post-translational processing can give an 
equivalent or even functionally superior product. Intermediate-valued products can be 
economically viable because corn grain biorefining allows the generation of several products 
in addition to the protein stream, such as starch and oil that are converted into diverse 
industrial products. In 2007 a record of 92 million acres of corn were planted in the United 
Sates with an expected yield of over 350 million tons of grain (1). About 75% of the crop 
was available for domestic animal feed and industrial use in 2007 (2). There is extensive 
experience with the cultivation and handling of genetically modified corn in the United 
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States. as in 2007 over 73% of the U.S. corn crop was planted with transgenic plants 
designed for herbicide and insect tolerance (3). Hence, there is no shortage of potential cost-
effective co-production of so-called “Plant Made Industrial Proteins” (PMIP) required at 
large volumes (thousands of metric tons per year) and low cost (less than US$100/kg). 
Examples of potential PMIP applications are drug delivery (e.g. gelatin for capsules), 
bioprocessing (e.g. cellulases, lignases, xylanases, proteases, amylases, lipases, isomerases 
for feedstock conversion to biofuels), consumer products (e.g. detergent enzymes, fabric-
treatment enzymes, bleaching enzymes, antifreeze peptides), antibiotic peptides, hazardous 
biological agent deactivating proteins (e.g. butyrylcholinesterase as a protective agent against 
organophosphate poisoning), and advanced performance protein-based polymers (e.g. silk, 
elastin). 
We selected one such protein, a recombinant collagen fragment, potentially 
compatible with high-volume, economical co-production in a corn-based biorefinery. 
Recombinant collagen fragments generated from yeast fermentation have been used as 
substitutes for animal-derived gelatin, a denatured collagen-derived industrial protein used 
extensively in food, photography, and other pharmaceutical applications (4, 5). Over 50,000 
metric tons of gelatins are consumed every year just for pharmaceutical use, with over 80% 
of this material used to manufacture capsules for the oral delivery of drugs and nutraceuticals. 
Use of plant-derived products, especially in pharmaceutical applications, could avoid the 
allergenicity and safety concerns related to animal-derived contaminants, lack of traceability, 
and inconsistent product quality due to the variability of tissue origin and animal age.  
The currently preferred recombinant technology for gelatin production is based on the 
yeast Pichia fermentation (5).  The recombinant Pichia production system has been 
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developed to produce many recombinant collagen fragments (from 8 to 100 kDa), as well as 
fully prolyl hydroxylated triple-helical recombinant collagen when paired with the co-
expression of the human enzyme prolyl 4-hydroxylase (P4H) (4-6). Studies using a series of 
the Pichia-derived recombinant collagen I α1 (rCIα1) fragments ranging in size from 56 to 
1014 amino acids indicated that these recombinant collagen fragments can be used as 
replacement for animal-derived gelatin for many of the current medical applications (5). 
CIα1 is the most common type of collagen found in animal-derived gelatin. The rCIα1 
fragments are secreted in Pichia fermentation as fully intact species as determined by 
electrophoresis gels, N-terminal sequencing, gel filtration chromatography and mass 
spectrometry. The accumulation of recombinant collagen and of collagen fragments has also 
been demonstrated in other recombinant expression systems such as mammalian cells (7-9), 
insect cell culture(10, 11),  Escherichia coli (12, 13), Bacillus (14), silkworms (15), milk of 
transgenic animals (16, 17) and other yeasts (Sacchromyces cerevisiae (18, 19), Hansenula 
polymorpha (20, 21)).  
The degree of hydroxylation provided during expression is important to the functional 
properties of collagen because it modulates gelation and triple-helix formation (5, 22). 
Partially prolyl hydroxylated recombinant collagen was produced in tobacco cell cultures co-
expressing a cloned animal P4H enzyme (5) and tobacco plants (23, 24). Transgenic tobacco 
cell cultures accumulated recombinant type-III collagen co-expressed with human P4H in a 
triple-helical conformation with 75% of the prolyl hydroxylation level found in collagen 
obtained from human tissue (5).  Lack of prolyl hydroxylation when CIα1 accumulated in 
tobacco without cloned animal P4H suggested that any plant endogenous P4H is not able to 
hydroxylate proline at a detectable level (24). Recent studies indicated that transient and 
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stable expression of CIα1 can be achieved in barley and rice suspension cell culture (25, 26) 
and in barley and corn seeds (27, 28).   
Consistently high accumulation levels (10-40 kg recombinant protein/acre, 2.5-10 g 
/kg grain) using tissue-specific promoters in high yielding commercial lines producing up to 
4000 kg grain/acre will be required for the commercialization of recombinant PMIP. This 
high level of recombinant PMIP accumulation has been achieved after extensive selection 
and crossing. For example, the accumulation level for a recombinant avidin was increased 
150-fold to 10 g avidin/kg grain in eight generations compared with the accumulation seen in 
the first transgenic grain (29-36). The early generation transgenic plants usually have very 
low levels of recombinant protein accumulation for characterizing the expressed protein. 
Thus, this report describes the development of a recovery and purification process for a 
recombinant collagen fragment derived from corn grain with low accumulation level (20 
mg/kg) typical from the initial field trials conducted in the early stages of the development 
program. It is at this stage that characterization will be important because it could reveal 
molecular changes as produced in the seed or as may occur during grain handling and 
processing. 
The collagen extraction was patterned after studies showing that pH and ionic 
strength have the greatest effects on protein extraction from grain. The total extractable corn 
endogenous protein concentration increased 10-fold when increasing the pH from 3 to 10 (29, 
37). The total extractable corn endogenous protein concentration also increased with addition 
of NaCl up to 300 mM (29). Collagen fragments are acid soluble (24) and Pichia-derived 
CIα1 showed maximum solubility at pH 1-2, offering the possibility for selective extraction 
of CIα1 at low pH. Pichia-derived gelatin (6) and tobacco-derived collagen (38) were 
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purified using ion-exchange chromatography (IEC) eluted with acetate buffer. Gel filtration 
chromatography should be able to remove the remaining corn grain-related impurities as 
most of the extractable corn endogenous proteins at acidic pH are expected to be smaller than 
30 kDa (39). 
The characterization of the corn–derived 44 kDa CIα1 was based on the analysis of 
its immunoreactivity to CIα1-specific antibodies, amino acid composition determination, 
glycosylation staining, and mass spectrometry and peptide mapping to assess the fidelity of 
translation and post-translational modifications.  Analytical data of the corn grain-derived 
CIα1 were compared with data from the Pichia-derived analogous CIα1 fragment. Previous 
publications of corn grain-derived recombinant proteins have focused on the production and 
downstream processing, providing only limited protein characterization data for non-
glycosylated 6.5kDa aprotinin (29), β-glucuronidase (GUS), and avidin (34). The most 
extensive characterization was for corn-derived trypsin, for which Western blotting, MS, and 
glycosylation staining were used (35). All analytical results of the corn seed-derived trypsin 
were equivalent to the native protein with the exception of the molecular weight of the 
extracted protein. The differences in molecular weight were attributed to O-linked 
glycosylation of the corn-derived protein, demonstrated by the molecular weight after 
chemical deglycosylation. Karnoup et al. (40) showed that O-linked glycosylation found in a 
corn grain-derived human IgA was through hydroxylated proline residues indicating that a 
maize prolyl hydroxylase was able to convert proline to hydroxyproline and subsequently 
glycosylate IgG1. The cloned CIα1 fragment does not contain the consensus sequences for 
N-linked glycosylation. The only possibility for glycosylation is O-linked glycosylation, 
which could occur through serine, threonine or any hydroxylated proline or lysine residues. 
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Materials and Methods  
 
Materials 
The transgenic corn grain expressing the 44 kDa CIα1 was provided by the former 
ProdiGene Inc. (College Station, TX).  This grain was harvested in the fall of 2004 from a 
field trial in Nebraska growing second-generation transgenic plants containing the gene for 
the expression of a 44 kDa collagen fragment of the triple-helical region of human CIα1. The 
CIα1 fragment has 498 amino acids resulting in a calculated MW of 44,002.8 Da, assuming 
proper cleavage of the signal sequence; its estimated pI is 8.1. Upon receipt at Iowa State 
University (ISU), the seeds were stored at 4oC.  A lyophilized 44 kDa CIα1 of the same 
sequence produced in Pichia pastoris (Pichia-derived 44 kDa CIα1) was provided by 
FibroGen Inc. (South San Francisco, CA) to be used as reference material. 
 
Vector Construction and Transformation of Corn-derived 44 kDa CIα1 
ProdiGene used the corn expression vector PGN9004 to clone the gene for the 44 kDa 
CIα1 fragment between the Hind III and Not I sites of the vector.  The expression of the 44 
kDa CIα1 gene was regulated by an embryo-specific maize globulin-1 promoter (PGNpr2) 
(41).  The pin-II transcription terminator from the protease inhibitor II gene from potato (42) 
was used in this construct. For transgenic calli selection the phosphinothricin acetyl 
transferase gene was included in the vector under the control of the CaMV 35S promoter.  
This gene confers resistance to the herbicide bialaphos (43-45). The expression vector 
provided a signal sequence - barley alpha amylase signal sequence - to direct 44 kDa CIα1 to 
the cell wall.   
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The resultant vector was introduced into corn immature embryos using 
Agrobacterium transformation (46). The Hi-II maize line was used as host which initiates 
Type II embryogenic callus in culture selected using bialaphos (47). The use of the Hi-II calli 
growth medium (47) results in redifferentiation of the plant cells and regeneration into a plant 
allowing the scutellum cells to become embryogenic callus.    
Embryos were cultured to recover 20 independent transgenic events and regenerated 
to recover transgenic first-generation (T0) plants. The first generation seeds (T1) produced 
from the T0 plants were transferred to a greenhouse to produce T1 plants that were pollinated 
using pollen donors from elite high yielding inbreds lines. The Hi-II maize line that is used in 
tissue culture for plant transformation has poor agronomic characteristics and is not high-
yielding in the field.  The T2 seeds were collected and planted in the field trial generating the 
grain (T3) used for this study. 
 
Corn Grain Fractionation and Defatting 
The 44 kDa CIα1-containing corn grain was separated into germ-rich and endosperm-
rich fractions by using a dry milling procedure established at the Center for Crops Utilization 
Research (CCUR) at ISU (48). The germ-rich fraction was milled into flour using a 
household coffee mill (GE, model 169028) and then defatted. Defatting was carried out by 
mixing the ground germ-rich corn flour with hexane (1:5 w/v) using a magnetic stir bar for 
60 min at 0oC. The supernatant was decanted after centrifugation (15 min, 2000g, 23oC) and 
the flour then extracted a second time as above. The residual hexane in the flour was 
removed by air drying at room temperature. 
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Recombinant 44 kDa CIα1 Recovery 
The extraction was designed to recover the corn grain-derived 44 kDa CIα1 with 
minimal co-extraction of the endogenous corn grain components thus reducing the 
complexity of the extract for the subsequent chromatographic steps. The defatted germ-rich 
corn flour was extracted twice by mixing with extraction buffer (0.1M phosphoric acid, 0.15 
M sodium chloride, pH 1.8) in a ratio of 1:5 w/v for 3 h at room temperature. The extracts 
were clarified by centrifugation (~3000g, 10 min  at 23oC),  then pooled and dialyzed (Pierce 
SnakeSkin T Dialysis Tubing, 3.5K MWCO) overnight at 4oC against sodium acetate buffer 
(50 mM, pH 4.6). The dialyzed extract was filtered through a 0.45 µm membrane (GV 
Durapore PVDF, Millipore) before chromatography. 
 
Recombinant 44 kDa CIα1 Purification 
The dialyzed extract was fractionated by cation-exchange chromatography (CEC) 
using a XK16/20 column (GE Healthcare) packed with 12 ml of SP SepharoseTM Fast Flow 
resin (Sigma) equilibrated with 50 mM sodium acetate (pH 4.6).  The elution was carried out 
over 15 column volumes using a salt concentration gradient from 0 to 0.5 M sodium chloride 
in 50 mM sodium acetate (pH 4.6) at 3 ml/min flow rate.  The collected fraction with highest 
44 kDa CIα1 content as determined by ELISA was concentrated 5X using a Centriplus YM3 
(Amicon, 3K MWCO) filter before proceeding to the next chromatographic step. The 
concentrated CEC pool was further purified by gel filtration chromatography (GFC) using a 
XK 16/40 column (GE Healthcare) packed with 70 ml of Sephacryl S-200HR GFC medium 
(GE Healthcare). Protein elution was carried out with a 50 mM sodium acetate, 0.15 M 
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sodium chloride (pH 4.6) buffer at a flow rate of 0.5 ml/min. The two fractions with highest 
44 kDa CIα1 content as determined by ELISA were used for the characterization studies. 
 
Total Soluble Protein Assay 
Total soluble protein concentration was determined using the Coomassie Plus - The 
Better Bradford™ Assay Kit (Pierce). Bovine serum albumin (BSA) was used as standard. 
Protein concentration was the average of three replicate assays.   
 
Enzyme-Linked ImmunoSorbent Assay (ELISA) 
A competitive ELISA was used to determine the 44 kDa CIα1 concentration. A 96-
well plate (Corning Costar High Binding Cat# 3590) was coated with 2 μg/ml of streptavidin 
(Zymed #43-4301) in PBS (Mediatech #21-040-CV) and incubated at 4oC overnight. 
Biotinylated Pichia-derived 44 kDa CIα1 (125 ng/ml  in assay buffer (100 mM PBS, 0.05% 
Tween 20, 0.1% BSA, 0.1% Kathon CG/ICP, pH 7.0)) was then immobilized to the plate by 
incubation with the streptavidin at 4oC overnight and worked as a competitor against corn 
grain-derived 44 kDa CIα1 for the primary antibody. The primary antibody was a rabbit 
polyclonal antibody (FibroGen), raised against a Pichia-derived 25kDa CIα1, and used at 
1:4000 dilution. The 25kDa CIα1 was part of the 44 kDa CIα1, and this antibody was 
reactive with both. Horseradish peroxidase (HRP) –conjugated goat anti-rabbit IgG (H+L) 
(Invitrogen) was used as the secondary antibody at a 1:5000 dilution. Both primary and 
secondary antibodies were diluted in the assay buffer. A SureBlueTM TMB substrate solution 
(Kirkegarrd & Perry Laboratories) was used as the substrate for the HRP conjugate and 
incubated with it at ambient temperature (23oC) for 30 min. The plate was then read at 450 
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nm on a microplate reader (EL340, BioTek Instruments).  Pichia-derived 44 kDa CIα1 of 
known concentration was the standard for the quantification of the corn grain-derived 44 kDa 
CIα1.    
 
SDS-PAGE, Western Analysis, and Glycosylation Detection 
 SDS-PAGE was carried out by following the manual of the Ready Gel® Precast Gels 
Application Guide (BioRad) using a Mini-PROTEAN® II Electrophoresis Cell (BioRad).  
Protein samples were diluted in the sample buffer described in the Application Guide at a 1:1 
ratio and heated at 100oC for 5 min before being loaded to a 4-15% Tris-HCl precast gel 
(BioRad).  The Pichia 44 kDa CIα1 was used as reference material. 
For Western analysis, the protein bands from the gel were transferred to a 
polyvinylidene difluoride (PVDF) membrane (Invitrogen) after SDS-PAGE.  The membrane 
was incubated with a rabbit polyclonal antibody (primary antibody with 1:4000 dilution) 
overnight at 4oC,  followed by incubation with horseradish peroxidase (HRP) –conjugated 
goat anti-rabbit IgG (H+L) (Invitrogen) (secondary antibody with 1:5000 dilution) for 1 h at 
23oC.  An ECL plus Western blotting detection system (Amersham Biosciences, RPN 2132) 
was used to visualize the immunoreactive protein bands.  The membrane was exposed to a 
Fuji Super Rx film (Fisher Scientific, 0444199) for about 30 sec and the film was 
subsequently developed in a FuturaTM 2000K automatic X-ray film processor (Fischer 
Industries, Inc.).   
A Gelcode Glycoprotein Staining Kit (Pierce) was used to detect the presence of 
glycosylation in the purified corn 44 kDa CIα1. After SDS-PAGE, the gel is stained with the 
kit reagents resulting in only the protein bands containing glycoproteins developing a 
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magenta color. A replicate gel was stained with Coomassie Brilliant Blue to visualize all the 
proteins. 
 
Intact Protein Mass Determination by Mass Spectrometry (MS) 
MALDI-TOF (Matrix-Assisted Laser Desorption Ionization-Time of Flight) MS was 
used to measure the mass of the intact protein. The GFC pooled fractions with the highest 44 
kDa CIα1 content were further purified to remove impurities by reverse phase high-pressure 
liquid chromatography (RP-HPLC) (Phenomenex, Jupiter C4, 5μm, 300Ǻ, 250 x 4.6 mm) 
before the MS analysis.  The elution was carried out using a linear gradient of 30-60 % 
acetonitrile in 0.1% trifluoroacetic acid over 30 min at 1 ml/min flow rate. The isolated 44 
kDa CIα1 was freeze-dried, reconstituted with DI water, and then mixed with 3, 5-
dimethoxy-4-hydroxy-cinnamic acid (sinapinic acid) used as the matrix. The mixture was 
spotted on a MALDI sample plate and air-dried. The external calibration was performed 
using bovine serum albumin. The analysis was done using a Voyager-DE STR MALDI-TOF 
MS (PerSeptive Biosystems) in the Protein Facility at ISU. 
 
Internal Peptide Sequencing by Tandem MS  
Two types of proteolytic digestions were performed for individual analysis by MS.  
Sequencing-grade trypsin (Promega) was added to the corn 44 kDa CIα1 at an enzyme to 
substrate ratio of 1:20 (w/w) in 50 mM ammonium bicarbonate buffer, pH 7.8 with the 
digestion carried out for 3 h at 37oC.  Sequencing grade endoproteinase Glu-C (New England 
Biolabs) was added to the 44 kDa CIα1 at an enzyme to substrate ratio of 1:20 (w/w) in 50 
mM Tris-HCl, 0.5mM Glu-Glu, pH 8.0 (New England Biolabs) with the digestion carried out 
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for 18 h at 23oC.  Both digests were diluted 2X with 50% methanol and 0.5% formic acid, 
and the resultant solutions were further purified and concentrated using a C18 ZipTip pipette 
tips (Millipore).  About 20 μl of each solution were loaded separately to the ESI-quadrupole-
TOF tandem mass spectrometry (Qstar XL, Applied Biosystems). Analysis of the MS and 
tandem MS (MS/MS) spectra data was done using the Mascot computer algorithm which 
allows for peptide amino acid sequence interpretation. A self-defined database with the 
human CIα1 amino acid sequence containing the expected sequence for the 44 kDa CIα1 
fragment was selected and used for the analysis. Both MS spectra collection and amino acid 
sequence interpretation were carried out in Proteomics Facility at ISU. 
 
N-terminal Sequencing  
The purified corn grain-derived 44 kDa CIα1 was further separated from minor 
impurities by SDS-PAGE, and transferred to a PVDF membrane. The 44 kDa region band 
was cut out and loaded onto the Procise protein sequencer (Applied Biosystems). Cycles of 
Edman degradation were conducted followed by injection onto RP-HPLC. The first 20 amino 
acids on the N-terminus were sequenced. The sequencing was performed at the ISU Protein 
Facility with confirming results provided by FibroGen Inc. 
 
Amino Acid Composition Analysis 
For the amino acid composition analysis, the PVDF membrane excised 44 kDa CIα1 
band from SDS-PAGE was subjected to hydrolysis under vacuum (6 N HCl, 150oC, 65 min).  
The resultant amino acids were then derivatized with phenylisothiocyanate (PTC) by using a 
PTC derivatizer (Perkin Elmer Applied Biosystems Model 420A), and analyzed by a PTC 
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Amino Acid Analyzer (Perkin Elmer Applied Biosystems Model 130A).  A  Pichia-derived 
44 kDa CIα1 (in liquid solution instead of a PVDF extracted band) was also submitted and 
analyzed for comparison. Trans-4-hydroxy-L-proline (Sigma H5534) was used as standard 
for quantifying the hydroxyproline content. The amino acid composition of the 44 kDa CIα1 
samples was performed at the ISU Protein Facility. 
 
Results and Discussion 
A summary of the results of the recovery and purification process is provided in 
Table 1.   
Protein Extraction 
The total soluble protein (TSP) extracted (Table 1) from the 5 g of corn germ-rich 
flour represents less than 10% of the maximum TSP in corn germ due to the low pH of the 
extraction buffer. This value is similar to those obtained by other researchers using acidic pH 
for extraction (37). Recovery of 44 kDa CIα1 from the enriched germ fraction was calculated 
at 120 mg 44 kDa CIα1/kg corn germ fraction at a 2% purity based on TSP in this acidic 
extract.  Analysis of the grain before fractionation to obtain the enriched germ used for the 
extraction indicated a concentration of 20 mg 44 kDa CIα1/kg corn grain consistent with 
values seen in the seed used for planting the field trial. To achieve commercially acceptable 
levels it will be required to increase the CIα1 accumulation level in corn grain at least 50-to 
250-fold to achieve 1 to 5 g of 44 kDa CIα1/kg corn grain. With a similar system ProdiGene 
achieved levels for a recombinant avidin of 10 g/kg grain that was 150-fold higher than the 
accumulation seen in the first transgenic grain (T1) (32).  
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Table 1. Purification of the corn grain-derived 44 kDa CIα1  
Step Volume (ml) 
Protein 
(µg) 
44 
kDaCIα1 
(µg) 
Purity 
by ELISA* 
(%) 
Purity 
by gel** 
(%) 
Step 
purification 
factor*** 
Yield 
(%) 
Extract 67 20,971 433 2.06 1.2 1 100 
IEC 
 
8 1,370 316 23.10 10 11.2 73 
GFC  
     load 0.9 1,119 259 23.10 10 ― ― 
  pooled 10 76.5 213 100 70 4.3 82 
 
* Purity by ELISA was based on the amount of 44 kDa CIα1 as determined by ELISA and 
total protein as determined by Coomassie blue protein assay using BSA as a reference 
standard. The difference between the sample and reference proteins leads to overestimates of 
purity when the sample purity was high and concentration was low because collagen gives a 
low reading in this assay.  
** Purity was estimated by the densitometric analysis of SDS polyacrylamide gel stained 
with Coomassie Brilliant Blue where dye-binding by collagen would result in low estimates 
of purity.  
*** Step purification factor was determined by the purities calculated with ELISA, and 
overall purification factor was 48.5.  
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Corn-derived 44 kDa CIα1 Purification 
Figure 1 shows the elution profile of the 44 kDa CIα1 from the first chromatographic 
step, the cation-exchange column. No significant amount of the 44 kDa CIα1 was detected 
during the sample loading and washing steps, indicating that the 44 kDa CIα1 was effectively 
captured by the column. The 44 kDa CIα1 was eluted within the first main peak, as shown by 
the black arrow in Figure 1, and collected mainly in three fractions.  One of these fractions 
was an order of magnitude richer in 44 kDa CIα1 than the other two and it was carried 
forward for the second chromatographic step. This fraction was 11X-enriched, 23% pure, and 
contained 73% of the 44 kDa CIα1 loaded to the column (Table 1).  
Figure 2 shows the elution profile of the 44 kDa CIα1 from the second 
chromatographic step (GFC). The 44 kDa CIα1 eluted mainly over two fractions before the 
elution of the majority of the native corn proteins as shown by the arrow in Figure 2. The 
yield of 44 kDa CIα1 for this purification step was 82% with a purity of 100%  based on the 
ratio of 44 kDa CIα1 content to the total protein content in the pooled fractions. This purity is 
based on ELISA for the CIα1 fragment and the total protein assay by using BSA as a 
standard.  An alternative estimate based on densitometry using the SDS-PAGE gels (Figure 3, 
lane 4) yielded a purity value of 70%. The discrepancy between the two purity results stems 
from the low binding of the dye by collagen in the two assays.  
SDS-PAGE was used to monitor the purification process performance (Figure 3).  
The extract (Lane 2) mainly consists of proteins smaller than 25 kDa, assuming that there are 
not many multimeric proteins. The 44 kDa CIα1 was partially enriched after the cation-
exchange step (Lane 3), and further purified after the GFC step (Lane 4). While some native  
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Figure 1. Elution profile of corn grain-derived 44 kDa CIα1 from SP-Sepharose® Fast Flow 
cation exchange chromatography. The elution was carried out over 15 column volumes of a 0 
to 0.5 M sodium chloride gradient in 50 mM sodium acetate (pH 4.6) at 3 ml/min.  The arrow 
shows the region where 44 kDa CIα1 was eluted. (Buffer B: 0.5 M sodium chloride + 50 mM 
sodium acetate). 
 
 
  
61
 
Figure 2. Elution profile of corn grain-derived 44 kDa CIα1 from Sephacryl S-200HR gel 
filtration chromatography.  Elution was carried out with 50 mM sodium acetate plus 0.15 M 
sodium chloride (pH 4.6) at 0.5 ml/min.  The arrow indicates the region where 44 kDa CIα1 
was eluted.  Two fractions, each with 5 ml/fraction, were collected. 
 
 
44kDa CIa1 eluted
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corn proteins with MW similar to the 44 kDa CIα1 remained in the GFC product fraction, 
most small corn proteins were removed during this step.  The Pichia-derived 44 kDa CIα1 
(first band in Lane 5) is shown for comparison and shows that the corn-derived 44 kDa CIα1 
had a very similar MW to its Pichia counterpart. The MWs of both corn and Pichia-derived 
44 kDa CIα1 estimated from the gel were about 60 kDa, 36% higher than the expected MW 
of 44 kDa.  A similar phenomenon was reported by Werten et al.(49) when analyzing a 36.8 
kDa recombinant collagen fragment produced from Pichia pastoris.  Their explanation was 
that the collagen fragment’s high hydrophilicity resulted in low binding to the SDS, leading 
to slower migration.  
 
Immunorecognition 
Western analysis demonstrated the immunoreactivity of the corn grain-derived 44 
kDa CIα1 (Figure 4). The Pichia-derived 44 kDa CIα1 was also included in this analysis for 
comparison. The results showed that the corn grain-derived CIα1 had a very similar 
molecular weight to its Pichia counterpart, and that both the corn and the Pichia- derived 44 
kDa CIα1s were reactive to the same 25kDa CIα1 specific antibody confirming the reactivity 
seen in the ELISA.  A faster migrating corn grain-derived 44 kDa CIα1 immunoreactive 
protein band was observed when the sample loading to the gel is higher (lane 4, Figure 4).  
Similar phenomena were reported by others producing CIα1 fragments. Werten et al (50) 
reported that CIα1 fragment produced by Pichia pastoris was susceptible to proteolytic 
degradation. Other heterologous proteins expressed in corn had also shown susceptibility to 
proteolytic degradation.  A rootworm-control recombinant protein expressed in genetically 
modified corn plants exhibited a proteolytic fragment with MW slightly smaller than the 
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Figure 3. Coomassie Brilliant Blue -stained SDS-PAGE: Lane 1, protein marker; Lane 2, 
corn grain-derived 44 kDa CIα1 extract; Lane 3, IEC fraction; Lane 4, GFC pooled fractions; 
and Lane 5, Pichia-derived  44 kDa CIα1. The arrow indicates the position of the 44 kDa 
CIα1. 
 
 
 
 
Figure 4. Western blotting: Lane 1and 2, corn grain-derived 44 kDa CIα1 extract; Lane 3 
and 4, purified corn grain-derived 44 kDa CIα1; Lane 5 and 6, Pichia-derived 44 kDa CIα1 
supplied by FibroGen. For all the lanes above, the two lanes next to each other are loaded 
with different amounts of the same materials.
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target protein in Western blotting (51). Therefore it is reasonable to suspect that the observed 
faster migrating protein is a proteolytic fragment resulting from of the activity of corn grain-
derived endogenous proteases during crop growth, grain storage or protein extraction. The 
proteolytic fragment was not observable until the protein was purified and enriched at the 
later stage of the purification process (lane 4, Figure 3). 
 
Intact Protein Mass Determination by MS 
The MW of the intact corn grain-derived 44 kDa CIα1 was measured by MS.  The 
measured intact protein mass of the corn grain-derived 44 kDa CIα1 was estimated from MS 
to be 44,088 Da, which is within 0.2% of the mass (44002 Da) calculated from the amino 
acid sequence expected from the gene used for transformation. The accuracy for this MS 
analysis as provided by the manufacturer is ±0.05% for a 16 kDa protein.  However, for 
proteins with larger size, accuracy would be worse.  Adams et al., (52) reported an average of 
0.43% difference between measured intact mass by MS and the expected mass when using 
the same type of MALDI-TOF to analyze zein proteins (ranging from 10-30 kDa) in corn 
kernel. Therefore the 0.2% mass difference in this work is estimated to be within the 
accuracy range of the equipment and should not be considered as evidence for protein 
modification. The intact protein mass of the 44 kDa CIα1 provided reliable evidence that the 
corn-derived 44 kDa CIα1 was correctly expressed in the corn without significant post-
translational modification.  
 
Peptide Sequencing by Tandem MS  
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Tandem MS can be used to verify that a particular protein is being produced with as 
little as two to three peptides corresponding to 10-15% sequence coverage (53) on the basis 
of the low probability of another protein containing the same combination of peptides. 
Complete sequence coverage is recommended to identify all possible post-translational 
modifications on amino acid residues. To yield high overlapping sequence coverage for 44 
kDa CIα1, two proteolytic enzymes, trypsin and endoproteinase Glu-C, were used to perform 
digestions. Trypsin predominantly cleaves proteins at the carboxyl side of lysine and arginine, 
except when either is followed by proline, while Glu-C cleaves peptide bonds C-terminal to 
glutamic acid residues. Theoretical analysis of these digestions for the expected amino acid 
sequences with the two enzymes was performed by an online program (Protein Prospector 
http://pospector.ucsf.edu) predicting complementary coverage for the 44 kDa CIα1. 
Sequence coverage of the corn grain-derived 44 kDa CIα1 resolved by tandem MS with both 
trypsin and Glu-C digestion is shown in Figure 5.  Less sequence coverage was obtained 
from the Glu-C digest (28%) than from the trypsin digest (64%). Glu-C digestion generated 
longer peptides since it had fewer cleavage sites on the 44 kDa CIα1 than trypsin. The longer 
peptides often contained more basic amino acid residues, which could lead to the formation 
of ions with higher charge state. The highly charged peptides are usually more difficult to 
fragment further in generating the MS/MS spectrum data (54), thus resulting in reduced 
sequence coverage. The large 54-amino acid tryptic fragment from 454G (glycine) to 507P 
(proline) in Figure 5, which was not resolved by tandem MS, contained only two potential 
cleavage sites for trypsin.  The theoretical digestion of the fragment with Glu-C by the 
program Protein Prospector yielded ten short fragments, ranging from 11-23 amino acids. 
The range represents an ideal peptide length for MS fragmentation and analysis (53). The 
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actual digestion of the fragment with Glu-C yielded four peptides, from which a 54-amino 
acid fragment was totally resolved as shown in bold italics of Figure 5.    
It should be noted that the MS-MS data could not rule out the possibility of errors in 
the unmatched sequences.  Limited instrument sensitivity and incomplete MS spectra make it 
extremely difficult to obtain 100% coverage (55).  However, the 79% sequence coverage 
confirmed by tandem MS and N-terminal sequencing and the agreement of intact MW 
obtained in this work provide confidence that the 44 kDa CIα1 produced from the corn was 
consistent with the gene used for the expression with minimal post-translation modification. 
 
 
 
 
   351     GLPGAK GLTGSPGSPG PDGKTGPPGP AGQDGRPGPP GPPGARGQAG  
   401 VMGFPGPKGA AGEPGKAGER GVPGPPGAVG PAGKDGEAGA QGPPGPAGPA  
   451 GERGEQGPAG SPGFQGLPGP AGPPGEAGKP GEQGVPGDLG APGPSGARGE  
   501 RGFPGERGVQ GPPGPAGPRG ANGAPGNDGA KGDAGAPGAP GSQGAPGLQG  
   551 MPGERGAAGL PGPKGDRGDA GPKGADGSPG KDGVRGLTGP IGPPGPAGAP  
   601 GDKGESGPSG PAGPTGARGA PGDRGEPGPP GPAGFAGPPG ADGQPGAKGE  
   651 PGDAGAKGDA GPPGPAGPAG PPGPIGNVGA PGAKGARGSA GPPGATGFPG  
   701 AAGRVGPPGP SGNAGPPGPP GPAGKEGGKG PRGETGPAGR PGEVGPPGPP  
   751 GPAGEKGSPG ADGPAGAPGT PGPQGIAGQR GVVGLPGQRG ERGFPGLPGP  
   801 SGEPGKQGPS GASGERGPPG PMGPPGLAGP PGESGREGAP GAEGSPGRDG  
   851 SP 
 
Figure 5. Combined sequence coverage 79% resolved by tandem MS with both trypsin and 
Glu-C digestion, and by N-terminal sequencing. The 44 kDa CIα1 starts at 355G, and ends at 
852P. Peptides in bold are derived from trypsin digestion (64% coverage), peptides in bold 
italic are from Glu-C digestion (28% coverage), and the peptides in bold and underline are 
the overlapped sequences.
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N-terminal Sequencing 
The first 20 amino acid residues at the N-terminus, 
“GLPGAKGLTGSPGSPGPDGK”, all match that expected from the gene sequence, 
confirming the identity of the 44 kDa CIα1 and indicating that the signal sequence was 
properly cleaved.   
 
Amino Acid Analysis 
Amino acid analysis (Table 2) showed that the corn grain-derived 44 kDa CIα1 was 
similar to its Pichia counterpart for all the amino acids measured except in the proline and 
hydroxyproline content. While Pichia is not able to hydroxylate proline (5), corn seed seems 
to be capable of hydroxylating prolines though to a limited degree compared with the level 
obtained in human collagen . The 2% hydroxyproline content in the corn grain-derived 44 
kDa CIα1 suggested the presence of an endogenous prolyl hydroxylase in corn seed and that 
mammalian prolyl 4-hydroxylase (P4H) co-expression will be necessary to obtain higher 
levels of hydroxylation in corn seed. The accumulation of hydroxylated CIα1 fragments has 
been reported earlier in both constitutive, glucose-fed fermentations and methanol-induced 
yeast Hansenula polymorpha fermentations, but only when a complex nutrient source 
(peptone) was added to the media (21). No hydroxylation was observed when the 
fermentation was conducted with a medium containing only salts and methanol (56).  In 
contrast, when the same fragment was expressed in Pichia in the presence of peptone, no 
hydroxylation occurred. Hydroxyproline was also absent in all other CIα1 fragments 
expressed in Pichia, indicating that the presence of an endogenous prolyl hydroxylase 
activity was specific to Hansenula (21).
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Table 2. Amino acid composition of the corn grain-derived 44 kDa CIα1 
Amino acid Pichia 44 kDa 
CIα1 (%) 
Corn 44 kDa 
CIα1 (%) 
Human type I 
homotrimer * (%) 
Hydroxyproline 0 2.01 10.8 
Proline 23.71 16.35 12.4 
Glycine 29.56 29.39 33.3 
Aspartic acid 4.91 5.99 4.2 
Glutamic acid 8.45 8.07 7.3 
Serine 3.02 4.47 3.4 
Histidine 0 0.53 0.3 
Arginine 4.84 4.53 5.0 
Threonine 1.56 2.00 1.6 
Alanine 13.38 13.08 11.5 
Tyrosine 0.11 0.66 0.1 
Valine 2.17 3.09 2.1 
Methionine 0.49 0.76 0.7 
Isoleucine 0.70 1.35 0.6 
Leucine 2.20 2.71 1.9 
Phenylalanine 1.32 1.45 1.2 
Lysine 3.61 3.57 2.6 
 
* Values based on the literature (57) 
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Glycosylation and Phosphorylation 
The amino acid analysis showed 2% hydroxyproline in the corn-derived 44 kDa CIα1. 
Hydroxylated proline residues represent potential sites for glycosylation. However, neither 
corn nor Pichia-derived 44 kDa CIα1s showed any bands (Figure 6) indicating glycosylation.  
This glyscosylation staining method can detect the presence of carbohydrate groups in as 
little as 0.625 ng avidin and 0.16 µg horseradish peroxidase. The amounts of corn and 
Pichia-derived 44 kDa CIα1 loaded to the gel were estimated to be about 2.5 μg, which was 
about 4000 times that of the detectable avidin and 16 times the detectable horseradish 
peroxidase.  
The Mascot computer algorithm used to process the MS spectrum data allowed us to 
search for any potential phosphorylated amino acid residues.  None were identified in the 
corn-derived 44 kDa CIα1.  
 
 
Figure 6.  SDS-PAGE gels stained by Coomassie Brilliant Blue (A) or Pierce GelCode 
glycoprotein staining kit (B). Lane 1, MW markers; Lane 2, HRP (positive control of 
glycoprotein, 40 kDa); Lane 3, soybean trypsin inhibitor (negative control, 20 kDa); Lane 4, 
corn grain-derived 44 kDa CIα1 (GFC fraction #2); Lane 5, Pichia-derived 44 kDa CIα1.  
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Conclusions 
Protein extraction with 0.1M phosphoric acid buffer at low pH efficiently recovered 
the corn-derived 44 kDa CIα1 while minimizing the co-extraction of the contaminating host 
proteins.  The combination of CEC and GFC was effective in purifying the corn grain-
derived 44 kDa CIα1, present at low concentration in corn extract, at lab scale for 
biochemical characterization.  Data from immunorecognition, MW measurement, internal 
peptide sequence analysis, N-terminal sequencing, and glycoprotein detection provided 
reliable evidence that the corn grain-derived 44 kDa CIα1 was faithfully expressed from the 
recombinant DNA construct transformed into the corn plants with proper cleavage of the 
signal sequence, a small degree of proline hydroxylation, and no further detectable post-
translational modification. This provides first indication of an endogenous corn enzyme able 
to prolyl-hydroxylate collagenous proteins, a step important to the proteins functional 
properties. 
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CHAPTER 3. PURIFICATION AND CHARACTERIZATION OF 
RECOMBINANT COLLAGEN TYPE I alpha 1 FROM 
TRANSGENIC CORN SEED 
 
A paper to be submitted to Biotechnology Progress 
Cheng Zhang1, Julio Baez2, and Charles E. Glatz3 
 
Abstract 
The use of collagen and gelatin produced from animal sources poses quality and 
safety concerns related to compositional heterogeneity, possible allergic reactions and 
contamination by animal-derived components.  In the present paper we discuss the use of a 
transgenic corn expression system for the production of a 100 kDa human collagen type I 
alpha 1 (CIα1) chain that could be developed as a compositionally homogeneous and safe 
substitute for animal-derived gelatin. While other recombinant proteins have been expressed 
in corn, producing collagen raises untested post-translational challenges for this host. In 
addition to obtaining the correct primary sequence, signal sequence processing, proline 
hydroxylation, and triple helix structure formation were all desired. The expression of CIα1 
was directed to the seed by an embryo-specific maize globulin-1 promoter. The corn-derived 
CIα1 was extracted from ground grain using a low pH buffer (0.1M phosphoric acid, 0.15M 
NaCl, pH 1.8) to minimize the extraction of endogenous corn contaminating proteins while 
allowing the efficient recovery of CIα1. The accumulation level of CIα1 was determined to 
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2 Co-author, supplying information and materials on collagen/gelatin assays and chemistry  
3 Author for correspondence 
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be 0.04% of extractable proteins at low pH, creating a challenge for obtaining purified 
protein for characterization.  Available anti-collagen polyclonal antibodies proved ineffective 
for affinity capture.  Thus, purification was carried out by ultrafiltration/diafiltration followed 
by four chromatographic steps resulting in CIα1 with close to 100% purity and 16% recovery 
yield.   Compared with related animal-derived collagens, the purified recombinant CIα1 had 
a low level of prolyl hydroxylation (~1.23%).  The CIα1 chains folded into a triple-helical 
structure with a melting temperature around 26oC.  The 29 amino acid foldon fused to the C-
terminus to initiate triple helix formation  was not cleaved from the CIα1chains, but could be 
removed by pepsin treatment following recovery. The amino acid composition and 
immunoreactivity of the purified CIα1 was as expected and similar to that of an analogous 
CIα1 produced in Pichia.  Tandem mass spectrometry confirmed the primary sequence of the 
corn-derived 100 kDa CIα1 with 46% coverage. Fragments of the CIα1 chains were also 
observed, possibly caused by plant endogenous proteases. 
 
Key words: recombinant collagen, human type I collagen, gelatin, protein extraction, 
purification, characterization, chromatography, transgenic corn, maize.  
 
Introduction 
Gelatin, derived from collagen, is extensively used in food, photography, and 
pharmaceutical applications such as vaccine stabilization, resuscitation fluids, and as the 
structural component of capsules and tablets.  Over 50,000 metric tons of gelatins are 
consumed every year for these pharmaceutical applications, with over 80% of this material 
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used to manufacture capsules for the oral delivery of drugs and nutraceuticals. These gelatins 
are produced mostly from porcine and bovine skins and bones by acid or base extraction 
(Olsen, et al. 2003).  Sourcing gelatins from animals create several concerns.  Foremost is a 
concern for potential allergic reactions and the possibility of pathogenic contaminants, such 
as prions (Olsen, et al. 2005).  In addition, products containing animal-derived components 
are rejected by a growing number of people due to religious or nutritional preferences.  In 
terms of product quality, animal-derived gelatin lacks source traceability, structural 
homogeneity, and consistent composition due to the variability of tissue origin and animal 
age.  The use of recombinant technology can deliver custom-tailored recombinant gelatin 
using a defined, traceable source and process resulting in a product of consistent size, 
structure, and physical properties.  Production of properly-assembled recombinant collagens 
and gelatin would have numerous applications and their production has been demonstrated in 
many recombinant systems (Olsen, et al. 2003; Baez, et al. 2005). 
For the present study we used corn as the expression system.  The use of a crop, such 
as corn, with well defined genetic and agronomic traits as host is attractive for the production 
of high-volume (thousand metric tons per year) and low-cost (below US$100/kg) industrial 
proteins particularly if the recombinant protein can be recovered as a co-product in corn-
based biorefineries.  We have previously shown that a 44 kDa recombinant human collagen I 
alpha 1 (CIα1) chain fragment expressed in corn had the expected composition (Zhang, et al. 
2008).  That molecule was a single chain consisting of ca. 50% of the helical domain of CIα1.   
Naturally occurring collagens contain a helical domain with a repeating gly-X-Y 
composition, with proline as the predominant X or Y amino acid, and non-helical domains 
flanking the helical domain.  These include C- and N-terminal propeptides and C- and N-
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terminal telopeptides that play important roles in helping form triple helical structures (Gelse 
et al., 2003).  In the present work, the complete helical region of human collagen I alpha 1 
chain was cloned in corn with the telopeptides. The normal C-propeptide, which is thought to 
be involved in initiating the formation of the triple-helical structure was replaced by a 29 
amino acid foldon (Pakkanen, et al. 2003). The foldon was reported to be effective in 
facilitating the assembly of triple-helical structure in human type I and III collagen molecules.  
Expression without the N-propeptide did not prevent the formation of correctly folded 
collagens, suggesting it does not play an important role in collagen assembly (Ruggiero, et al. 
2000; Baez, et al. 2005).  
One critical element for producing functional collagens is that the recombinant 
production system can elicit the required post-translational modifications on the nascent 
collagen to produce a protein that can be used as a replacement for native collagen or gelatin.  
After their synthesis, the native procollagen chains are directed into the lumen of the 
endoplasmic reticulum (ER) by the signal peptide, which is then cleaved before assembly of 
the triple-helical collagen. Before assembly within the ER a specific enzyme, prolyl 4-
hydroxylase (P4H), catalyzes the regiospecific hydroxylation of prolines.  The extent of 
hydroxylation determines the thermal stability of the mature triple-helical collagens.  The 
triple-helical procollagen containing the telopeptides and propeptides is converted into 
mature collagen by removing the N- and C-propeptides. The removal of the propeptides is 
considered an essential step for subsequent fibril formation (Gelse, et al. 2003).  
The currently preferred recombinant system for collagen and gelatin production is 
fermentation using the yeast Pichia pastoris (Olsen, et al. 2003; Baez, et al. 2005). In the P. 
pastoris system, the triple-helical procollagens accumulate within the ER and are not 
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secreted into the culture medium.  Cell lysis and proteolytic treatment (using pepsin) are 
required for triple-helical collagen recovery (Vuorela, et al. 1997; Keizer-Gunnink, et al. 
2000; Myllyharju, et al. 2000; Baez, et al. 2005). The triple-helical structures are resistant to 
pepsin while non-triple-helical regions and most other host-related proteins are digested 
(Bruckner and Prockop 1981).    
Previous recombinant systems used for collagen production cannot properly 
hydroxylate the prolines, presumably because the host cells lack sufficient endogenous P4H 
activity. Because the degree of hydroxylation determines melting temperature of the 
procollagen and the properties of the derived gelatin, the recombinant system used for 
collagen production had been modified by cloning the mammalian P4H to perform the 
required hydroxylation. Collagens expressed in P. pastoris (Keizer-Gunnink, et al. 2000) and 
Saccharomyces cerevisiae(Olsen, et al. 2001) were not hydroxylated without co-expression 
of the P4H.  Recombinant human CIα1 expressed in tobacco had a very low content (~0.5%) 
of hydroxylated prolines, though the low hydroxyproline content did not prevent the correct 
formation of triple-helical structure (Ruggiero et al., 2000).  Co-expression of a heterologous 
P4H increased the hydroxyproline content in  tobacco (Merle, et al. 2002) and yeast 
(Myllyharju, et al. 2000; Nokelainen, et al. 2001; Pakkanen, et al. 2003).  
To characterize the corn-derived CIα1, it was necessary to obtain a pure preparation 
to determine the amino acid composition and formation of triple-helical structure.  The low 
expression level (~3 mg of CIα1/ kg of seeds) resulting from the first field trial conducted 
using the early generation corn grain and the lack of a suitable affinity adsorbent challenged 
this purification.  In the present study, we report the development of a purification process 
consisting of a combination of membrane filtration and conventional non-affinity 
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chromatography.  Previous corn seed extraction studies indicated that the use of acidic pH 
and optimized ionic strength would minimize the extraction of corn host proteins, thus 
reducing the complexity of the extract for the subsequent purification (Azzoni, et al. 2002; 
Zhong, et al. 2007).  Purification of recombinant collagens and gelatins produced from other 
hosts used a combination of precipitation with a single chromatographic step such as ion 
exchange chromatography (IEC)(Olsen, et al. 2001; Perret, et al. 2001). In some cases, gel 
filtration chromatography (GFC) (Myllyharju, et al. 2000; Nokelainen, et al. 2001) was used 
instead of IEC.  However, these previous studies had higher CIa1 accumulation (e.g. 0.5 g/l).  
The combination of low concentration of ~3 mg collagen/kg of corn seeds and the low purity 
(~0.04%) in the corn extract ruled out the use of the precipitation that had been effective in 
the earlier work.  To deal with this low purity and concentration, a purification process 
composed of multistep chromatography was pursued in this work.  
The characterization of the corn-derived CIα1 included immunoreactivity to CIα1-
specific antibodies, amino acid composition, N-terminal sequencing, mass spectrometry and 
peptide mapping, performed to assess the fidelity of translation and of potential post-
translational modifications.  Results for the corn grain-derived CIα1 were compared with 
data from the Pichia-derived analogous CIα1.  In the present work we 1) show the expression 
of a full-length collagen  α1 chain in cereal for the first time, 2) demonstrate the effectiveness 
of the purification process that we have developed without affinity chromatography to purify 
an extremely low abundance protein in a complex corn protein extract for the purpose of 
protein property characterization, and 3) establish the fidelity of expression including 
whether the expressed CIα1 chains could be correctly processed to mature collagens and 
whether corn has endogenous proline hydroxylation activity.  
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Materials and Methods 
Materials 
Transgenic corn grain containing CIα1 targeted for expression to the germ was 
provided by former ProdiGene Inc. (College Station, TX).  The CIα1 gene codes for a 1086 
amino acid (calculated MW and pI of 98.03 kDa (nominally 100 kDa) and 9.2, respectively) 
protein, including the N and C telopeptides and the foldon peptide at the C terminus.  Upon 
receipt, the grain was stored at 4oC.  A CIα1 derived from the yeast P. pastoris (termed as 
Pichia-derived CIα1) with the same sequence was provided by FibroGen Inc. to be used a 
reference material. 
Tris base, sodium chloride, sodium acetate, acetic acid, sodium phosphate dibasic, 
and phosphoric acid were purchased from Fisher Scientific (Itasca, IL). All chemicals were 
reagent grade. 
 
Vector Construction and Transformation of Corn CIα1 
Vector and transformation were performed by former ProdiGene (College Station, 
TX). DNA encoding the human 100 kDa CIα1chain (without N-propeptide) was used to 
make the construct. The C-propeptide in the CIα1 gene was replaced by a 29-amino acid 
peptide foldon that facilitates chain assembly (Pakkanen, et al. 2003). The ProdiGene corn 
expression vector PGN9004 was used to clone the gene for CIα1 between the Hind III and 
Not I sites of the vector.  The gene (Figure 1a) consisted of the triple-helical domain, N- and 
C-telopeptides, and the foldon. Expression was regulated by an embryo-specific maize 
globulin-1 promoter (PGNpr2) (Belanger and Kriz 1991). The pin II transcription terminator 
from the protease inhibitor II gene from potato (An, et al. 1989) was used (Figure 1b).   For  
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Figure 1. Schematic representations of the recombinant CIα1 chain (a) expressed in corn, 
and the expression vector (b) for CIα1 (the chain lacks the N-propeptide and the C-
propeptide was replaced by a smaller foldon. Domains are not drawn to scale. 
BAASS=barley alpha amylase signal sequence) 
 
transgenic calli selection the phosphinothricin acetyl transferase gene was included in the 
vector under the control of the CaMV 35S promoter.  This gene confers resistance to the 
herbicide bialaphos (Anzai, et al. 1989; Gordonkamm, et al. 1990; Uchimiya, et al. 1993). 
The expression vector also contained the barley alpha amylase signal sequence (BAASS)   
The vector was introduced into corn immature embryos which were regenerated to recover 
transgenic plants, as described in the production of the 44 kDa CIα1 chain fragment (Zhang, 
et al. 2008).   
 
Corn Seed Grinding and Defatting 
The CIα1-containing corn kernels were first coarsely milled using a Witt corrugated 
mill (Witt Corrugating Inc., Wichita, KS), further ground into flour with a household coffee 
grinder (GE, Fairfield, CT), and then defatted.  Defatting was carried out by mixing the 
ground corn flour with hexane (1:5 w/v) using a magnetic stir bar for 60 min at 0oC. The 
supernatant was decanted after centrifugation (15 min, 2000g, 23oC) and the flour was then 
Pin II terminator CIα1 chain
Embryo-specific 
promoter BAASS
(b) 
foldon
C-telopeptideN-telopeptide 
triple-helical domain
(a) 
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extracted a second time as before. The residual hexane in the flour was removed by air 
drying at room temperature. 
 
Extraction 
Extraction conditions were chosen to extract CIα1 with minimal co-extraction of 
native host proteins, thus reducing the complexity of the extract for the subsequent 
chromatographic steps. The defatted corn flour was extracted twice with extraction buffer 
(0.1M phosphoric acid, 0.15 M sodium chloride, pH 1.8) in a ratio of 1:5 w/v for 1 h at room 
temperature with stirring.  The extracts were clarified by centrifugation (~3000g, 10 min, 
23oC), then pooled for later concentration and diafiltration by tangential flow filtration (TFF). 
 
Ultrafiltration (UF)/Diafiltration (DF)  
Polyethersulfone membranes of 30, 50 and 100 kDa MWCO (PM30, PBQK, PBHK, 
Millipore Corp, Bedford, MA) were evaluated (Amicon model 8400 ultrafiltration cell, 
Millipore Corp. Bedford, MA) with the MWCO resulting in highest CIα1 recovery and 
highest flux used for the preparative procedure.  UF/DF was carried out in TFF mode 
(Pellicon 2 Mini Ultrafiltration Module; Biomax-50 polyethersulfone membranes; 0.1 m2 
area) for concentrating the extract and buffer exchange. The filtration was carried out at 
constant cross flow rate to obtain ca. eight-fold concentration. The diafiltration was carried 
with eight diavolumes in a discontinuous mode by repeatedly diluting the sample with an 
equal volume of dialysis buffer (20 mM sodium phosphate, pH 7.0) followed by two-fold 
concentration. 
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Chromatography Development  
For cation-exchange chromatography (CEC) three buffers were screened: 50 mM 
sodium acetate pH 4.8, 20 mM sodium phosphate, pH 7.0, and 50 mM HTris-Cl.  The elution 
was carried out over 15 column volumes (CV) with 0 to 0.5 M sodium chloride gradient in 
each buffer.  The eluting buffer providing highest purity was chosen for the purification.  
For the development of a hydrophobic interaction chromatography (HIC) step, a 
loading buffer salt concentration sought that promoted adsorption but did not cause 
precipitation of CIα1.  Ammonium sulfate was added to the CEC elution pools (to the level 
of 1.25 M) prior to loading to the HIC column. The buffers that did not cause precipitation at 
this step were used to screen three HIC resins for best separation performance: Octyl 
Sepharose TM Fast Flow, Phenyl Sepharose TM Fast Flow (Sigma, St. Louis, MO), and Phenyl 
Sepharose TM High Performance (GE Healthcare, Uppsala, Sweden).  The resin resulting in 
highest purity of eluted CIα1 was chosen for this step.  
 
Purification:  
The purification sequence is shown in Figure 2, with column loading shown in Table 
2. Concentrated and dialyzed protein extract was fractionated on a cation-exchange column 
(XK16/20 column, GE Healthcare, Uppsala, Sweden) packed with 30 ml of SP SepharoseTM 
Fast Flow resin (Sigma, St. Louis, MO) that had been equilibrated with 20 mM sodium 
phosphate, pH 7.0 (buffer A). The elution was carried out in stepwise mode from 0 to 0.2 M 
sodium chloride in buffer A over 3.5 CV at 3 ml/min flow rate. The fraction with highest 
CIα1 content was dialyzed (Pierce SnakeSkin T Dialysis Tubing, 10K MWCO, Pierce, 
Rockford, IL) overnight at 4oC against buffer A. 
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Figure 2. Flow diagram and running conditions for the chromatographic steps of the corn-
derived CIα1 purification from concentrated and dialyzed corn extract. 
 
   Dialysis 
Resin: 
30 ml SP Sepharose 6 
FF resin packed in a 
XK16/20 column 
 
Elution:  
stepwise, 200 mM NaCl 
in 20 mM sodium 
phosphate pH 7 
Feed 
Resin: 
8 ml SP Sepharose HP 
resin packed in a 
Tricorn 10/100 column;  
  
Elution:  
Gradient 7.5 CV over 0-
0.1 M NaCl in 20 mM 
sodium phosphate pH 7 
Resin: 
1ml Phenyl Sepharose 
HP column.  
 
Elution:  
Gradient,15CV over 
1.25 M (NH4)2SO4 to 0 
in 20 mM sodium 
phosphate 
CEX I 
Purified CIa1 
HIC 
GFC 
Resin: 
70 ml Sephacryl S-200 
HP resin in XK 16/40 
column.  
  
Elution:  
Isocratic, 1.5CV in 20 
mM sodium phosphate 
pH 7 plus 0.15 M NaCl  
CEX II 
Large 
loading      
Short 
process 
time  
High 
resolution 
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The dialyzed fraction was applied onto a Tricorn 10/100 column (GE Healthcare, 
Uppsala, Sweden) packed with 8 ml SP Sepharose High Performance resin (GE Healthcare, 
Uppsala, Sweden). The elution was carried out over 7.5 CV of 0 to 0.1 M sodium chloride 
gradient in buffer A at 1 ml/min flow rate. Fractions containing CIα1 were pooled and 2.5 M 
ammonium sulfate in buffer A was added to a final concentration of 1.25 M ammonium 
sulfate. The solution was loaded to a HIC column packed with 1 ml of Phenyl Sepharose™ 
High Performance resin (HiTrap Phenyl HP, GE Healthcare, Uppsala, Sweden). The elution 
was carried out over 15 CV of 1.25 to 0 M ammonium sulfate gradient in buffer A.  Fractions 
containing CIα1 were pooled and concentrated with a centrifugal filter (Amicon Ultra-4, 
Millipore, Bedford, MA). The  concentrated sample (~ 1 ml) was then loaded onto a XK 
16/40 column (GE Healthcare, Uppsala, Sweden) packed with 70 ml of Sephacryl S-200HR 
GFC medium (GE Healthcare, Uppsala, Sweden). Proteins were eluted in buffer A plus 0.15 
M sodium chloride at 0.5 ml/min flow rate. The fraction with highest CIα1 content was used 
for characterization. 
 
Protein Sequencing by Tandem Mass Spectrometry (MS) 
The purified corn-derived CIα1 was denatured in 6M guanidine-HCl, 50 mM Tris-
HCl (pH 8) and 2mM dithiothreitol (DTT) at 60oC for 45 min followed by protease 
(sequencing grade trypsin, Promega, Madison, WI) digestion for 3 h at 37oC at an enzyme to 
substrate ratio of 1:20 (w/w) in 50 mM ammonium bicarbonate buffer, pH 7.8.  The digest 
was diluted 2X with 50% MeOH and 0.5% formic acid and the resultant solution was 
purified and concentrated with C18 ZipTip (Millipore, Bedford, MA).  About 20 μl of 
sample was loaded to an ESI-quadrupole-TOF tandem mass spectrophotometer (Qstar XL, 
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Applied Biosystems, Foster City, CA).  Full scan mass spectra were acquired and used to 
determine the precursor ions which were further fragmented to generate MS/MS spectra. 
Analysis of the MS and tandem MS (MS/MS) spectral data was performance using the 
Mascot computer algorithm, which allows for peptide amino acid sequence interpretation. A 
self-defined database of the human CIα1 chain amino acid sequence and the adjoining 
sequences used in the gene construct was searched. The trypsin digestion, MS spectra 
collection and amino acid sequence interpretation were carried out in the Proteomics Facility 
at Iowa State University (ISU). 
 
Protein Assay 
Total protein concentration was determined using the Pierce’s Coomassie Plus - The 
Better Bradford™ Assay Kit (Pierce, Rockford, IL), with bovine serum albumin as the 
standard.  The assay was done in triplicate and reported as the average.   
 
Enzyme-Linked Immunosorbent Assay (ELISA) 
CIα1 concentrations were determined by a competitive ELISA assay in which heat-
denatured Pichia-derived 100 kDa CIα1 (concentration:50 ng/ml) was immobilized at 4oC 
overnight in a 96-well plate (Costar High Binding Cat# 3590, Corning, NY) as a competitor 
against corn-derived CIα1 for the primary antibody. The primary antibody was a rabbit 
polyclonal antibody (#CA725, FibroGen, South San Francisco, CA), raised against a Pichia-
derived 25kDa CIα1, and used at 1:4000 dilution. The 25kDa CIα1 segment was part of the 
CIα1 and this antibody was reactive with both. Horseradish peroxidase (HRP) –conjugated 
goat anti-rabbit IgG (H+L) (Invitrogen, Carlsbad, CA) was used as the secondary antibody at 
  
89
 
a 1:5000 dilution. Both primary and secondary antibodies were diluted in the assay buffer 
(100 mM PBS, 0.05% Tween 20, 0.1% BSA, 0.1% Kathon CG/ICP, pH 7.0). A SureBlue™ 
TMB substrate solution (Kirkegaard & Perry Laboratories, Gaithersburg, MA) was used as 
the substrate for the HRP conjugate and incubated with it at ambient temperature (23oC) for 
30 min. The plate was then read at 450 nm on a microplate reader (EL340, BioTek 
Instruments, Winooski, VT).  Pichia-derived CIα1 of known concentration was the reference 
material for the quantification of the corn grain-derived CIα1.  
 
SDS-PAGE and Western Blotting 
SDS-PAGE was carried out according to the Ready Gel® Precast Gels: Application 
Guide (BioRad, Hercules, CA) in a Mini-PROTEAN® II Electrophoresis Cell (Bio-Rad, 
Hercules, CA). Proteins samples were diluted in equal volume of sample buffer (83 mM Tris-
HCl, pH 6.8, 2.7% (w/v) SDS, 25% glycerol, 0.02% Bromophenol Blue ,7% 2-
mercaptoethanol ) and heated at 100oC for 5 min before being loaded to a 4-15% Tris-HCl 
precast gel (Bio-Rad, Hercules, CA). After electrophoresis, the gels were silver stained (Bio-
Rad, Hercules, CA).  
In Western blotting analysis, the primary antibody used was either the anti-25kDa 
antibody as described above or an anti-foldon antibody (#CA 74550, FibroGen, South San 
Francisco, CA), and secondary antibodies used were the same as for the ELISA assay. After 
electrophoresis, the gel was transferred to a PVDF membrane (Invitrogen, Carlsbad, CA) and 
an ECL plus Western blotting detection system   (Amersham Biosciences, RPN 2132, 
Buckinghamshire, UK) was used to visualize CIα1 bands. The membrane was exposed to a 
Fuji Super Rx autoradiographic film (Fisher Scientific, 0444199, Itasca, IL) for about 30 sec 
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and the film was subsequently developed in a FuturaTM 2000K film processor (Fischer 
Industries, Inc. Geneva, IL).   
 
N-terminal Sequencing and Amino Acid Analysis 
The N-terminal sequencing was performed at the ISU Protein Facility.  The corn-
derived CIα1 fraction from the GFC column was loaded onto the Procise protein sequencer 
(Applied Biosystems, Foster City, CA). Cycles of Edman degradation were conducted 
followed by injection onto a RP-HPLC.  
For the amino acid analysis (also performed at the ISU Protein Facility), the purified 
corn-derived CIα1 was loaded to SDS-PAGE and transferred to a PVDF membrane. The 
excised CIα1 band was subjected to hydrolysis under vacuum (6 N HCl, 150oC, 65 min). The 
resultant amino acids were then derivatized with phenylisothiocyanate (PITC) by using a 
PTC derivatizer (Perkin Elmer, Applied Biosystems Model 420A, Foster City, CA ), and 
analyzed by a PTC Amino Acid Analyzer (Perkin Elmer, Applied Biosystems Model 130A, 
Foster City, CA). A  Pichia-derived CIα1 (in 10 mM HCl solution instead of a PVDF band) 
was also submitted and analyzed for comparison. Trans-4-hydroxy-L- proline (Sigma 
H5534), cis-4-hydroxy-L-proline (sigma H1637), and trans-3-hydroxy-L-proline (Sigma 
56244) were used as standards for quantifying the hydroxyproline content. The cis-4-proline 
and trans-3-proline standards were run at a later time than the samples, and the retention 
times were normalized with respect to the trans-4 standard run both times. 
 
Pepsin Resistance Study and Melting Temperature (Tm) Determination 
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The method to determine Tm is based on the pepsin-digestion resistance of the triple- 
helix form. Below its Tm, collagen is expected to have a triple-helical structure where pepsin 
does not have access to its cleavage sites.  Comparison of SDS gels before and after digestion 
reveals whether the sample was digested (i.e. was melted) or not (not melted).  Purified corn-
derived CIα1(~0.6-0.7 µg) was incubated for 15 min in a Polystat®  refrigerated bath (EW-
12111-10, Cole Parmer, Vernon Hills, IL ) at desired temperatures, and then treated with 
freshly prepared 150 µg/ml porcine pepsin solution (Sigma P6887, St. Louis, MO) at 2-8ºC 
for 16-18 h. Reactions were terminated by raising the pH above 6 with 2M Tris base.  The 
digests were analyzed by Western blotting. Tm was determined as the temperature when the 
CIα1 band disappeared.  For comparison, two Pichia-derived CIα1s (nonhydroxylated and 
hydroxylated) were also digested by pepsin, but analyzed with silver staining to determine 
Tm. 
 
Results and Discussion 
Expression of CIα1 in Corn 
With the intention to achieve high expression level in corn seeds, an embryo-specific 
maize globulin-1 promoter and a barley alpha amylase signal sequence (BAASS) were used 
in this study. The extractable CIα1 in the corn grain was found to be 3 mg/kg grain by ELISA. 
The same promoter and signal sequence combination had provided higher expression levels 
of other recombinant proteins in transgenic corn: laccase with accumulation level of  51 
mg/kg seed (Hood, et al. 2003; Bailey, et al. 2004), and brazzein of 400 mg/kg seed 
(Lamphear, et al. 2005).  Feasible commercial production would require accumulation above  
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0.1% (1 g/kg seeds) (Nandi, et al. 2005). 
 
Protein Extraction  
Our previous study to purify a 44 kDa CIα1 chain fragment used a 3-h extraction time 
(Zhang, et al. 2008). Extraction beyond 1 h did not yield any changes in either CIα1 or total 
extractable protein concentration in the extract. The content of the CIα1 in the extract was 
very low, about 0.25 μg/ml or 0.04% of the total soluble protein (TSP) in the extract. The 
TSP extracted at this acidic condition (0.1 M phosphoric acid, 0.15 M NaCl, pH as is (~1.8)) 
was  0.6 mg/ml  or 4.3 mg/ g seed, which is consistent with previous corn protein extraction 
studies (Azzoni, et al. 2002; Zhong, et al. 2007; Zhang, et al. 2008). The extraction condition 
maximized the CIα1concentration, as the CIα1 has higher solubility in acid pH than in 
neutral pH, and minimized the amount of soluble corn protein in the extracts, thus reducing 
the subsequent purification burden. Given that expression was targeted to the germ, dry-
milling to separate a germ-rich fraction would enrich and concentrate CIα1 prior to protein 
extraction, but this was not pursued in the present work.     
 
Protein Purification 
Of the three membranes tested for the initial UF/DF step, the 50kDa MWCO 
membrane was selected for its higher flux rate (thus shorter processing time) and no loss of 
CIα1 in the permeate.  The TFF, as shown in Table 1, reduced the extract volume from about 
2000 ml to about 250 ml (8X volume reduction). In addition, it removed more than 80% of 
the contaminating proteins, providing a purification factor close to 4. Thus, loading time and 
resin volume were both reduced for the subsequent chromatographic step.  Further, DF  
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Table 1. Summary of ultrafiltration and diafiltration (UF/DF) of corn extract 
 Collagen 
(µg/ml) 
Vol (ml) Purity (%) Purification 
factor 
Step yield 
(%) 
Protein 
Extract 0.25 2000 0.04 __ __ 
Retentate 0.59 250 0.15 3.8 30-50 
 
provided the required buffer exchange. The yield for the UF/DF step was only 30-50% due to 
adsorption of the CIα1 on the membrane surface (the CIα1 content was negligible in the 
permeate). A possible improvement would be to include a washing step or evaluate other 
membrane chemistry.     
Table 2 summarizes the outcomes of each chromatographic step.  A cation-exchange 
resin (sulphopropyl) was chosen to take advantage of the high pI (9.2) of CIα1. Of the three 
buffers/pHs tested in the CEC step development, the 20 mM sodium phosphate pH 7.0 gave 
the highest CIα1 purity and comparable yields in the CEC elution pools (data not shown).  
CEC was carried out in two steps providing step enrichments of 5.7 and 4.3 (Table 2). Two 
CEC steps were used because SP Sepharose FF resin in stepwise elution mode could 
accommodate the large sample loadings at high flow rate and the SP Sepharose HP resin in 
gradient elution mode could achieve high resolution.  
For the HIC step development, a small scale solubility test showed that ammonium 
sulfate concentration as high as 1.25 M did not cause any precipitation of CIα1. Therefore, 
two concentrations, 1.25 and 0.625 M, were evaluated for adsorption. While 0.625 M, led to 
CIα1 loss in the flow-through pool, 1.25 M ensured binding on all three HIC resins used.  
Phenyl Sepharose HP resin was selected for the final HIC step as it showed superior 
performance in both yield and step purification factors (Table 3).  After the CEC steps, the  
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Table 2. Summary of chromatographic steps of the purification process of corn-derived CIα1  
Step Volume (ml) CIα1 (µg) 
Protein 
(µg) Purity %* 
Step 
Purification 
Factor** 
Step Yield 
(%) 
Feed 250 149 101,125 0.15 __ __ 
CEC I 66 119 13,794 0.86 5.7 80 
CEC II 
 
16 76 2,049 3.71 4.3 76 
HIC 9 62 177 35.0 9.4 87 
SEC 5 68 66 103 2.9 100 
    Overall 668 53 
 
 
* Purity is based on the amount of 100 kDa CIα1 as determined by ELISA and total protein 
as determined by Coomassie blue protein assay using BSA as a reference standard.  
** Step purification factor is determined by the purities before and after the unit operation. 
 
 
 
Table 3. HIC step resin screening result 
Salt Concentration 
(m) Type of Resin 
Step Yield 
(%) 
Step Purification 
Factor 
Octyl FF 70 2 
Phenyl FF 85 4.5 1.25 
Phenyl HP 87 9.4 
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CIα1in the HIC pool was further enriched 9.4-fold (Table 2).   
CIα1 was collected in a single fraction (the chromatogram, not shown, evidenced a 
double peak) well before the elution of native corn proteins in the GFC step.  The longer 
retention time of the native proteins is consistent with evidence that ca. 60% of corn proteins 
extracted at acidic pH are 3-4 times smaller than the single CIα1chain (98 kDa) (Gu and 
Glatz 2007).   
The four chromatographic steps, in combination with UF/DF, achieved a combined 
purification factor of 2500 with an overall yield of 16%.  The purification process was also 
monitored by SDS-PAGE (Figure 3a) and the identity of the purified CIα1was confirmed by 
Western blotting (Figure 3b). While UF/DF (Lane 3, Figure 3a) removed most of 
contaminating host proteins, CEC (Lane 4) enriched both contaminating corn proteins and 
the product protein (CIα1). HIC (Lane 5) and GFC (Lane 6) removed impurities, yielding the 
purified CIα1.   
 
MW of CIα1  
The MW of corn-derived CIα1 estimated from the gel (lane 5, Figure 3(A)) was about 
120 kDa, 20% higher than the expected MW of 100 kDa for a single CIα1 chain. Such a 
discrepancy has been reported for collagens frequently and a variety of explanations based on 
collagen’s lower average amino acid size (Butkowski, et al. 1982), reduced chain flexibility 
(Manca, et al. 1997), and higher hydrophilicity (Werten, et al. 2001) have been used to 
explain this common observation. Additionally, two or three faint protein bands appear 
below the main “120 kDa” band (Lane 5). These could indicate that variable posttranslational 
cleavages have occurred. Multiple bands did not show up in the corresponding Western blot 
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(Figure 3 (B)); however, other bands did show immuno-reactivity (Figure 4) when higher 
sample loadings were used.  Apparent molecular weights of these bands ranged from 120 to 
70 kDa, consistent with the variable cleavage possibility.  The smaller fragments proved, by 
their susceptibility to pepsin digestion, that they were not able to form stable triple helices 
(Figure 5, panel B, lane 1).   
 
N-terminal Sequencing 
N-terminal sequence analysis revealed a peptide sequence “GXPGPXGAPGP”, 
which was nine amino acids downstream of the N-terminus of the triple-helical domain, 
providing more evidence that unintended proteolytic cleavage occurred. Several recombinant 
proteins expressed in corn with the same targeting via ER as used here have shown evidence 
of cleavage in the structural domain, including  a 44 kDa CIα1chain fragment (Azzoni, et al. 
2002; Zhong, et al. 2007; Zhang, et al. 2008), E1 endocellulase  and cellobiohydrolase I 
(Hood, et al. 2007). Since the content of the corn-derived CIα1 in the extract was very low, 
the fragments were not detectable until they were purified and concentrated. Therefore, it is 
uncertain whether the fragments were generated during the growth of the corn seeds, grain 
storage or the extraction and purification process. If the fragments were generated during the 
lengthy multistep purification process by concomitantly released plant proteases from 
extraction, inhibitors could be added during the protein extraction.  
  
Assembly of Triple-Helical Structure 
The continuing presence of intact CIα1 chains after pepsin digestion (Figure 5) is 
evidence of proper triple helix assembly and, in turn, the effectiveness of the foldon replacing 
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Figure 3.  SDS-PAGE of fractions thoughout the purification process visualized with silver 
staining (A), and western blotting with an anti-25 kDa CIα1 antibody (B).  Lane M, protein 
standard marker; lane 1, extract; lane 2, retentate of TFF; lane 3, CEC II pooled fractions; 
lane 4, HIC pooled fractions; lane 5, GFC pooled fractions. The bands in B are at the position 
corresponding to a molecular weight of 120 kDa. 
 
 
 
 
Figure 4. Western blot of purified CIα1 for different sample loadings. Lane 1: 0.5μg , Lane 2: 
0.3μg, Lane 3: 0.2μg, and Lane 4: 0.03μg).  Higher loadings reveal the presence of some 
smaller chains. 
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the native C-propeptide.  Also shown is that the Pichia-derived nonhydroxylated and 
hydroxylated CIα1s containing foldon are pepsin-resistant (Pakkanen, et al. 2003; Pakkanen, 
et al. 2006).  Without either the foldon or the C-propeptide, CIα1 produced from P. pastoris 
was reported to form unstable triple-helical structure (Pakkanen, et al. 2003). The presence of 
the foldon in the corn-derived CIα1 was confirmed by recognition with anti-foldon antibody 
in Western blotting (Figure 6, lane 1).  The foldon was removed by pepsin treatment (Figure 
6, lane 2). The presence of the foldon indicated that C-terminal processing (foldon cleavage) 
did not occur in the seed or during processing (extraction and purification). The same 
retention of the foldon occurred in P. pastoris (Pakkanen, et al. 2003).  Although effective in 
triple helix assembly, neither the C-propeptide nor the foldon was processed (removed) by 
the P. pastoris, and subsequent pepsin treatment was required to convert the procollagens to 
mature collagens (Myllyharju, et al. 2000; Nokelainen, et al. 2001; Pakkanen, et al. 2003; 
Baez, et al. 2005). Interestingly, CIα1 expressed in tobacco was processed to mature collagen 
simultaneously by concomitantly released endogenous tobacco proteases, thus eliminating 
the need for pepsin to cleave the N- and C-propeptides (Ruggiero, et al. 2000).  The 
differences in proteolytic action between corn and tobacco could be due to either the 
differences in the extraction conditions or in their endogenous proteases.  
Further comparison of the CIα1 chains without pepsin treatment (Figure 5, panel a) to 
those with pepsin treatment (Figure 5, panel b) revealed that all Pichia-derived hydroxylated 
CIα1chains were resistant to pepsin digestion, as the protein band intensity remained the 
same before and after pepsin treatment. In contrast, Pichia-derived non-hydroxylated CIα1 
chains and corn-derived chains were liable to pepsin digestion to some degree. The corn 
CIα1 chains were more susceptible to pepsin degradation as distinctly faint bands were
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Figure 5. Analysis of the assembly of CIα1 chains into triple-helical structures. Corn-derived 
CIα1(lanes 1), Pichia-derived non hydroxylated CIα1(lanes 2), and hydroxylated CIα1chains 
(lanes 3) were analyzed without pepsin treatment (A) and after pepsin digestion for 17 h at 4 
°C (B) by 4-15% SDS-PAGE under reducing conditions followed by silver staining. M 
represents a molecular weight marker. 
 
 
 
 
Figure 6. Western blot of corn-derived CIα1 with anti-foldon antibody before (lane 1) and 
after pepsin treatment (lane 2). (The molecular weight scale (shown as lane M) was derived 
from the original SDS-PAGE gel MW standards lane) 
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observed after pepsin treatment (Figure 5, panel b, lane 1), which indicated that the only a 
fraction of CIα1 chains produced by the transgenic corn assembled into the triple-helix, with 
the rest either forming deficient triple-helical structure or remaining as single chains. 
Whether the low hydroxyproline content (as will be shown below) hinders the correct triple-
helical structure formation, or the plant endogenous proteases have already cleaved some of 
the nascent CIα1 chains before they have a chance to assemble into the correct triple-helical 
structure is unknown.  
 
Amino Acid Composition, Proline Hydroxylation and Thermal Stability 
Amino acid analysis (Table 4) showed that the corn-derived CIα1 is similar to its 
Pichia-derived hydroxylated CIα1 and a human CIα1 for all the amino acids measured 
except for proline and hydroxyproline. The high levels of proline (ca. 20%) and glycine (ca. 
30%) are uniquely characteristic of collagens. The hydroxyproline content for corn-derived 
CIα1 is 1.23% of the total amino acids, corresponding to about 10% of the hydroxylated 
proline in native type I collagens. This result is slightly higher than that observed in tobacco-
derived CIα1(Ruggiero, et al. 2000), suggesting that a naturally occurring corn P4H is able to 
modify proline but only to a limited extent. Since hydroxylation of proline residues in 
collagen is an important post-translational modification and known to be critical for the 
thermal stability of the triple-helical domain, co-expression of heterologous proline 
hydroxylase with CIα1 would be necessary in transgenic plants for higher hydroxyproline 
content and thermal stability as reported previously in tobacco cell culture (Olsen, et al. 
2003).  All hydroxyproline was trans-4-hydroxyproline as neither cis-4-hydroxyproline nor 
trans-3-hydroxyproline was detected.   
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Table 4: Amino acid composition of CIα1 from several sources 
Amino acid Corn CIα1 (%) Pichia OH-CIα1 (%) 
Human type I 
homotrimer * (%) 
Hydroxyproline 1.23 11.54 10.8 
Proline 18.50 11.22 12.4 
Glycine 27.82 29.6 33.3 
Aspartic acid 5.04 5.58 4.2 
Glutamic acid 7.71 7.97 7.3 
Serine 4.43 3.75 3.4 
Histidine 0.75 0.32 0.3 
Arginine 5.14 5.40 5.0 
Threonine 2.20 2.17 1.6 
Alanine 12.45 10.93 11.5 
Tyrosine 0.91 0.47 0.1 
Valine 3.35 1.99 2.1 
Methionine 0.74 0.72 0.7 
Isoleucine 1.53 0.89 0.6 
Leucine 2.52 2.29 1.9 
Phenylalanine 1.55 1.54 1.2 
Lysine 4.12 3.62 2.6 
 
 * Values based on the literature (Miller and Gay 1982) 
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The melting temperature (Tm), an index of the thermal stability, for the corn-derived 
CIα1 is estimated to be 26-27oC based on the pepsin digestion study (Figure 7A). In 
comparison, Pichia-derived counterparts had Tm around 24-25oC for non-prolyl hydroxylated 
(Figure 7B) and 38-39oC for fully prolyl hydroxylated (Figure 7C). Since the Tm of the 
collagens has been reported to be directly related to the hydroxyproline content (Ruggiero, et 
al. 2000; Merle, et al. 2002), the difference in Tm confirms the differences in hydroxyproline 
content. As evidenced in Table 4, the hydroxyproline contents for corn-derived and Pichia-
derived CIα1s were 1.23 and 11.22%, respectively. Since the co-expression of P4H 
succeeded in increasing hydroxyproline content in other hosts, including tobacco cell culture  
(Myllyharju, et al. 2000; Merle, et al. 2002), the same strategy could be applied in transgenic 
corn.  By controlling the co-expression of P4H with CIα1, the level of proline hydroxylation 
could be tailored to suit different application.  
 
Internal Peptide Sequencing by Tandem MS  
 As shown in Figure 8, the confirmed sequence coverage from the MS data was 46%. 
This value was enough to confirm in the CIα1 identity, as literature uses as little as 10-15% 
sequence coverage to verify a protein being expressed (Liebler 2002). The MS data showed 
the existence of the telopeptide, resolved as the first peptide highlighted in red bold in Figure 
8. However, the N-terminal analysis data best matched the segment beginning nine-amino 
acids downstream of the N-terminal telopeptide.  The product may be a mix of collagens 
differing in the point of N-terminal processing as Figures 4 and 5 showed evidence of 
multiple forms in this preparation. However, N-terminal sequencing using the single excised 
band of the Figure 5 gel did not provide a matching sequence. 
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Figure 7. Analysis of the thermal stability of the CIα1 chains at different temperatures. Corn-
derived CIα1(A), Pichia-derived non hydroxylated CIα1(B), and Pichia-derived 
hydroxylated CIα1chains (C) were heated treated at specified temperature for 15 minutes, 
digested with pepsin for 17 h at 4oC, and subsequently analyzed by SDS-PAGE with silver 
staining (B and C) or Western blotting (A). M: protein standard marker, U: not digested.  
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     1   QLSYGYDE KSTGGISVPG PMGPSGPRGL PGPPGAPGPQ GFQGPPGEPG  
    51 EPGASGPMGP RGPPGPPGKN GDDGEAGKPG RPGERGPPGP QGARGLPGTA  
   101 GLPGMKGHRG FSGLDGAKGD AGPAGPKGEP GSPGENGAPG QMGPRGLPGE  
   151 RGRPGAPGPA GARGNDGATG AAGPPGPTGP AGPPGFPGAV GAKGEAGPQG  
   201 PRGSEGPQGV RGEPGPPGPA GAAGPAGNPG ADGQPGAKGA NGAPGIAGAP  
   251 GFPGARGPSG PQGPGGPPGP KGNSGEPGAP GSKGDTGAKG EPGPVGVQGP  
   301 PGPAGEEGKR GARGEPGPTG LPGPPGERGG PGSRGFPGAD GVAGPKGPAG  
   351 ERGSPGPAGP KGSPGEAGRP GEAGLPGAKG LTGSPGSPGP DGKTGPPGPA  
   401 GQDGRPGPPG PPGARGQAGV MGFPGPKGAA GEPGKAGERG VPGPPGAVGP  
   451 AGKDGEAGAQ GPPGPAGPAG ERGEQGPAGS PGFQGLPGPA GPPGEAGKPG  
   501 EQGVPGDLGA PGPSGARGER GFPGERGVQG PPGPAGPRGA NGAPGNDGAK  
   551 GDAGAPGAPG SQGAPGLQGM PGERGAAGLP GPKGDRGDAG PKGADGSPGK  
   601 DGVRGLTGPI GPPGPAGAPG DKGESGPSGP AGPTGARGAP GDRGEPGPPG  
   651 PAGFAGPPGA DGQPGAKGEP GDAGAKGDAG PPGPAGPAGP PGPIGNVGAP  
   701 GAKGARGSAG PPGATGFPGA AGRVGPPGPS GNAGPPGPPG PAGKEGGKGP  
   751 RGETGPAGRP GEVGPPGPPG PAGEKGSPGA DGPAGAPGTP GPQGIAGQRG  
   801 VVGLPGQRGE RGFPGLPGPS GEPGKQGPSG ASGERGPPGP MGPPGLAGPP  
   851 GESGREGAPG AEGSPGRDGS PGAKGDRGET GPAGPPGAPG APGAPGPVGP  
   901 AGKSGDRGET GPAGPAGPVG PAGARGPAGP QGPRGDKGET GEQGDRGIKG  
   951 HRGFSGLQGP PGPPGSPGEQ GPSGASGPAG PRGPPGSAGA PGKDGLNGLP  
  1001 GPIGPPGPRG RTGDAGPVGP PGPPGPPGPP GPPSAGFDFS FLPQPPQEKA  
  1051 HDGGRYYRAY IPEAPRDGQA YVRKDGEWVF LSTFLSPA 
 
Figure 8. Sequence coverage 46% (peptides in red bold) resolved by tandem MS with 
trypsin digestion. N- and C-telopeptides and foldon are underlined. 
 
 C-telopeptide 
  (Underlined) 
Foldon (bold) 
 N-telopeptide 
  (Underlined)  
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 Conclusions 
The combination of membrane filtration and four-step chromatographic steps was 
effective in purifying the corn-derived 100 kDa CIα1 present in low amount in corn extract. 
Data from immunoreactivity, MW estimation, amino acid composition and internal peptide 
sequence analysis provided reliable evidence that the corn-derived CIα1 was consistent with 
the DNA construct transformed into the corn plants.  A fraction of the expressed CIα1 
formed triple helices resistant to pepsin hydrolysis. The relatively low hydroxyproline 
content in the corn-derived CIα1 confirmed both some ability of corn to hydroxylate proline, 
but also the necessity of co-expression of a heterologous P4H if higher content is desired. 
Higher expression in future generations would simplify the purification process and perhaps 
reduce the proteolytic cleavage that may have occurred during this lengthy purification 
process.  
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CHAPTER 4. FRACTIONATION OF TRANSGENIC CORN 
SEED BY DRY AND WET MILLING TO RECOVER 
RECOMBINANT COLLAGENS 
 
A paper to be submitted to Biotechnology Progress 
Cheng Zhang1, Lawrence A. Johnson2, and Charles E. Glatz3 
 
Abstract 
Corn continues to be considered an ideal transgenic host for producing recombinant 
therapeutic and industrial proteins because of its potential for producing recombinant 
proteins at large volume and low cost. Efforts to reduce production costs have been primarily 
devoted to increasing expression level, optimizing protein extraction conditions, and 
simplifying purification. In the present work, we evaluated two fractionation methods, dry-
milling and wet-milling, to enrich two recombinant proteins, a recombinant 100-kDa human 
collagen type I alpha 1(CIα1) chain and a 44 -kDa CIα1 chain fragment, for the purpose of 
reducing the mass and impurity burden in subsequent protein extraction and purification. For 
both proteins, ca. 60% of the total CIα1 was recovered in the dry-milled germ-rich fractions 
making up ca. 25% of the total kernel mass. For wet milling, ca. 60% of the total CIα1 was 
recovered in three fractions accounting for 20-25% of the total kernel mass. The CIα1s in the 
dry-milled germ-rich fractions were enriched 3-6 times compared to the whole corn kernel, 
                                                 
1 Primary researcher and author, responsible for protein assays and data analysis 
2 Co-author, supplying technical support of corn milling processes   
3 Author for correspondence 
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while the CIα1s were enriched 4-10 times in selected wet-milled fractions. The recovered 
starch from wet milling was almost free of CIα1. Therefore, it was possible to generate CIα1-
enriched fractions with both dry and wet millings and a CIα1-free starch using wet milling. 
Using our procedure, dry milling could be accomplished on-farm, thus minimizing the risk of 
inadvertent release of viable transgenic seeds.          
 
Key words: recombinant proteins, human type I collagen, gelatin, protein extraction, 
transgenic corn, maize, dry milling, wet milling. 
 
Introduction 
Transgenic corn, along with a few other plants, has been extensively studied for the 
production of recombinant therapeutic and industrial proteins.  Corn offers the advantages of 
low-cost cultivation; easy scale-up (increased planted acreage); well-established practices for 
efficient harvesting, transporting, storing and processing; and elimination of animal-source 
pathogens (Menkhaus, et al. 2004; Stoger, et al. 2005; Sparrow, et al. 2007). The feasibility 
of commercially producing high-volume (thousands of metric tons per year) and low-value 
(less than US$100/kg) recombinant proteins, such as collagens or gelatins, however, requires 
not only high accumulation level, but also efficient utilization of transgenic biomass and 
realization of value-added co-product revenues.  
A typical approach to achieve high expression level is to target expression to a 
specific tissue. Advocates of germ targeting have used the embryo-preferred globulin-1 
promoter; and, as a result, they have reported higher expression levels of recombinant β-
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glucuronidase (GUS) (Witcher, et al. 1998), avidin (Hood, et al. 1997), fungal laccase (Hood, 
et al. 2003), bovine trypsin (Woodard, et al. 2003), and brazzein (Lamphear, et al. 2005) than 
when using constitutive or endosperm-preferred promoters. An added advantage for targeting 
expression to germ is the smaller amount of biomass entering downstream processing  
(Howard and Hood 2005) because germ is only 11% of the kernel mass (Johnson 2000).  
Effective milling processes for grain fractionation are required to realize this advantage and 
yield losses have been apparent in previous work. Recoveries in the germ-rich fractions were 
55% for recombinant avidin (Hood, et al. 1997) and 60% for recombinant β-glucuronidase 
(Yildirim, et al. 2002). A disadvantage associated with germ targeting is that a clean germ 
fraction is 33% oil, which could interfere with protein extraction and separation media 
(Kusnadi, et al. 1998), necessitating a defatting step. Another disadvantage is that the high 
content of soluble germ proteins increases the separation challenge, whereas endosperm 
consists mostly of starch and low solubility zeins. Protein extraction from endosperm with a 
neutral salt buffer would leave nearly 80% of the native proteins in the spent meal 
(Menkhaus, et al. 2004). These are reasons why others have targeted recombinant proteins to 
endosperm, e.g. in the production of lipases (Zhong, et al. 2006).  
Well-established dry- and wet-milling processes have been utilized by the milling 
industry to fractionate corn components for value-added products, but they have not been 
extensively studied to fractionate corn as a means to enrich recombinant proteins. Only a few 
studies on the dry-milling process for that purpose have been published (Hood, et al. 1997; 
Yildirim, et al. 2002) and no extensive study on the fractionation efficiency of the wet-
milling process for the recovery of recombinant proteins could be located. In the dry-milling 
studies, the corn kernel was separated into anatomical fractions (germ, endosperm, and bran). 
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Because the majority of the oil is accumulated in the corn germ, the oil content and recovery 
in each fraction were most commonly used as a natural measure of the purity of and germ 
endosperm fractions. Targeted expression of green fluorescent protein (GFP) was recently 
effectively used as marker (Shepherd, et al. 2008) for fractionation quality, but it would need 
to be co-expressed with the desired recombinant protein to improve on the oil measure for a 
specific grain. Typical oil content in an industrial dry-milled germ-rich fraction for producing 
food-grade corn grits and flour is about 23% db (Johnston, et al. 2005) , which corresponds 
to about 70% purity based on the assumption that pure germ contains 33% oil (Johnson 
2000). The simplified kg-scale dry milling process developed at Iowa State University does 
not reach this level – e.g. a recombinant dog gastric lipase (rDGL)-containing germ fraction 
with ca. 14% oil and 72% germ yield (Octaviani, personal communication), a recombinant β-
GUS-containing germ fraction with 12% oil and 44% germ yield (Yildirim, et al. 2002), and 
a GFP-containing germ fraction with 17% oil and ca. 60% germ yield (Shepherd, et al. 2008). 
The oil contents of the endosperm-rich fractions are typically less than 1% from an effective 
industrial dry-milling process. In the wet-milling process, the corn kernel is separated into a 
greater number of components (starch, gluten/protein, fiber, germ/oil).  
Compared to the dry-milled fractions, wet-milled fractions are purer and more 
suitable for use as ingredients or further refining (Johnson and May 2003). But the wet-
milling process breaks down the kernel structure by using aqueous solutions of sulfur dioxide 
and lactic acid (~ pH 3.2, (Vignaux, et al. 2006)), which are detrimental to some recombinant 
proteins (Yildirim, et al. 2002) and could well have the negative consequence of distributing 
soluble proteins into multiple fractions. 
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Our previous work has shown that 100-kDa CIα1 and a 44-kDa fragment of CIα1 
(termed 44-kDa CIα1, hereafter) can be expressed with germ targeting (Zhang, et al. 2008a; 
2008b). The purpose of this work is to evaluate how well milling processes can generate 
germ-rich fractions enriched in biologically active recombinant protein, reducing the mass to 
downstream processing with the rest available to be added to the usual biorefinery 
fermentation feed stream.   
 
Materials and Methods 
Grain 
Two transgenic corns, separately containing 100-kDa CIα1 and 44-kDa CIα1, were 
provided by former ProdiGene Inc (College Station, TX). Upon receipt at Iowa State 
University (ISU) the seeds were stored at 4oC. The expression vector contained a signal 
sequence for export to the cell wall via the endoplasmic reticulum (ER) (Zhang, et al. 2008a); 
on the basis of expression levels realized this appeared to have occurred for 44-kDa CIα1, 
but the 100-kDa CIα1 appeared to have ended up in the ER. 
 
Dry- and Wet-Milling Processes 
Dry milling was performed using a procedure developed at the Center for Crops 
Utilization Research (CCUR), ISU for fractionating rDGL-containing corn (Vignaux, et al. 
2004 ). Corn kernels were moisture-conditioned (at 21% moisture for 2.5 h), degermed, 
passed through roller mills and an aspirator, and fractionated through a series of sieves. A 
laboratory Beal-type drum degermer, which was most effective in rDGL corn fractionation, 
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was selected. The wet-milling process (Vignaux, et al. 2006) separates a 100-g batch into 
starch, gluten meal, germ, pericarp, coarse fiber and fine fiber fractions.   
 
CIα1 Distribution in the Corn Kernel  
To estimate the amount of the recombinant protein accumulated in pure germ, 100 g 
of each transgenic kernel was soaked in 300 ml of deionized water for 24 h. The germ, 
endosperm, and bran were separated by hand-dissection.    
 
Protein Extraction and Sample Analysis 
The extraction protocol was designed to recover the recombinant product with 
minimal co-extraction of the endogenous corn host proteins, thus reducing the complexity of 
the extract for subsequent purification. The milled fractions were further ground into flour 
using a household coffee mill (GE, Fairfield, CT). The fractions with oil contents >4% (i.e. 
the germ and the coarse fiber fractions and the whole corn kernel flour) were defatted before 
extraction. Defatting was carried out by mixing the ground corn flour with hexane (1:5 w/v) 
using a magnetic stir bar for 60 min at 0oC. The supernatant was decanted after centrifugation 
(15 min, 2000g, 23oC) and the extraction with hexane was repeated as before.  Residual 
hexane in the flour was removed by air drying at room temperature. The defatted corn flour 
was extracted twice by mixing with extraction buffer (0.1 M phosphoric acid, 0.15 M sodium 
chloride, pH 1.8) in a ratio of 1:5 w/v for 1 h at room temperature.  The extracts were 
clarified by centrifugation (~3000g, 10 min at 23oC), then pooled and filtered through a 
0.45µm membrane (GV Durapore PVDF, Millipore) before CIα1 and total soluble protein 
analysis. 
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The CIα1 concentrations in the extracts were quantified by a competitive ELISA 
(Enzyme-Linked ImmunoSorbent Assay) as previously described (Zhang, et al. 2008a; 
2008b). The total protein concentration in the extract was determined by using the Pierce’s 
Coomassie Plus - The Better Bradford™ Assay Kit (Pierce, Rockford, IL), with bovine 
serum albumin as the standard. All analytical assays were done in triplicate and reported as 
the mean.    
 
Oil and Moisture Analyses  
A Goldfisch apparatus (Labconco Corporation, Kansas City, MO) was used to 
determine the oil contents of ground samples by using hexanes in AACC Methods 30-26 
(AACC 2000). The amounts of extracted oil were measured gravimetrically. The moisture 
contents of the various fractions were determined by AACC Methods 44-15A (AACC 2000). 
 
Results and Discussion 
Dry-Milling Fractionation and CIα1 Distribution 
As shown in Table 1, the oil contents of the dry-milled germ-rich fractions were 10.8  
and 10.3% for the 44-kDa and 100-kDa CIα1s, respectively, with estimated germ purities in 
those fractions being 31-33% based on the assumption of ca. 33% oil in a typical pure germ 
(Johnson 2000). The germ-rich fraction of the 100-kDa CIα1 captured 48% of total oil found 
in the corn grain, while more oil (~59% of the total oil) was recovered in the germ-rich 
fraction containing the 44-kDa CIα1. In contrast, the endosperm-rich and bran-rich fractions 
from both 44-kDa and 100-kDa CIα1 corn grain have relatively high oil content (~3%)  
  
117
 
Table 1. Oil contents in fractions produced by dry milling  
Corn Type Fraction Mass Yield  (db %) 
Oil (db %) 
 
Total Oil 
(%) 
Germ 27 10.8 59 
Endosperm 67 2.7 38 44-kDa CIα1 
Bran 5 3.1 3 
Germ 22 10.3 48 
Endosperm 69 3.3 49 100-kDa CIα1 
Bran 6 2.6 3 
 
compared to that reported in literature (~1% oil in both fractions) (Johnson 2000), as a result 
of contamination with the remaining germ.  
The 31-33% germ purity obtained in our 100-kDa CIα1 and 44-kDa CIα1 containing 
germ-rich fractions was close to what has been achieved in dry-milling other transgenic corn,  
such as rDGL (Octaviani, personal communication) and a β-GUS-containing germ fraction 
(Yildirim, et al. 2002). Theoretically, proteins targeted to germ can be enriched 8- to 9-fold if 
a pure germ fraction can be obtained because germ only accounts for 11-12% of the total 
kernel mass, but the 31-33% germ purity achieved by the dry milling in this work indicated  
that germ was only enriched 3-fold with 50-60% recovery. 
The purity of the germ was increased by a modified milling procedure that passed the 
44-kDa CIα1-containing germ-rich fraction through one additional milling and sieving 
operation to generate a high purity (>60% germ) germ-rich fraction. This procedure enriched 
the already concentrated CIα1 three times to 120 mg/kg of dry solids, but the improvement 
was at the expense of lower germ (ca. 40%) and CIα1 (ca. 35%) yields. 
The CIα1 concentration and yield in the hand-dissected germ fraction provided an 
upper limit for judging the dry-milling process that eliminates germ loss and accounts for any  
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“leaky” expression from the embryo-preferred globin-1 promoter to endosperm. The hand-
dissected germs contained ca. 34% oil with the corresponding endosperm containing 0.7% oil, 
levels are consistent with the literature (Johnson 2000). As shown in Table 2, although only 
67% of total 100-kDa CIα1was located in the pure germ, it was concentrated 18 times (42.2 
µg CIα1/g of dry solids) compared to that in endosperm (2.3 µg CIα1/g of dry solids). 
Similarly, 62% of total 44-kDa CIα1was accumulated in the germ with concentration (175.8  
µg CIα1/g of dry solids) as much as 13 times that in endosperm (13.4 µg CIα1/g of dry 
solids).  
The dry-milling processes recovered 63% of the total 100-kDa CIα1 in a germ-rich 
fraction comprised of 22% of the total kernel mass (Table 3). This recovery was higher than 
that of oil recovery (Table 1), which might be anticipated because endosperm contamination 
of this fraction carries along more CIα1 than oil. However, for the 44-kDa CIα1 the recovery 
closely mirrored that of the oil (Tables 1 and 4). The difference could result from the 15-20% 
variation in the CIα1 ELISA assay. The 100-kDa CIα1 was 5.5 times enriched in the germ-
rich fraction (15.9 μg/g dry solids) compared to that in the whole corn kernel (2.9 μg/g dry 
solids). The 44-kDa CIα1 in the germ-rich fraction was 2.6-fold concentrated (49.6 μg/g dry 
solids) relative to the whole kernel (19.2 μg/g dry solids). Most of the rest of the 44-kDa 
CIα1 ended up in the endosperm-rich fraction. In general, dry-milling processes were capable 
of generating a CIα1-enriched fraction with CIα1 concentration close to one-half that in the 
pure germ fractions at ca. 60% CIα1 yield. It should be noted that the CIα1 yield of each 
fraction was calculated on the basis of the summation of CIα1s from all fractions, rather than 
the lower total CIα1s obtained from whole corn extraction (Table 3-6 footnotes). All dry 
fractions received a final milling by using a coffee grinder and the same extraction conditions  
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Table 2. CIα1 distributions by hand-dissection 
CIα1  
Corn Type Fraction Mass Yield (db %) μg/g dry 
solids 
Mass Yield 
(%) 
Purity in 
Extract (%)* 
Germ 11 175.8 62 1.94 
Endosperm 80 13.4 34 0.29 44-kDa CIα1 
Bran 9 14.9 4 0.22 
Germ 11 42.2 67 0.41 
Endosperm 86 2.3 30 0.05 100-kDa CIα1 
Bran 4 5.3 3 0.07 
* Purity in extract is defined as the concentration of the CIα1 divided by the total protein 
extracted under the extraction condition (0.1 M phosphoric acid, 0.15 M sodium chloride, pH 
1.8)  
 
in an effort to equalize the expected extractabilities. Nonetheless, the milled fractions had 
been previously submitted to multiple steps that could have increased the extraction yield and 
for the wet-milled liquid fractions the extractant was different.  
These germ-fraction recoveries were consistent with previously-referenced dry-
milling studies showing ca. 60% recovery. In contrast, close to 90% of rDGL was recovered 
in the dry-milled endosperm (Octaviani, personal communication). Because endosperm 
accounts for >80% of the kernel mass, the fraction of endosperm lost to the smaller germ and 
bran fractions was less, an inherent advantage of endosperm expression that offsets the lower 
biomass burden reduction. In addition, oil content was lower in the endosperm fraction and 
the amount of native corn proteins extracted from corn endosperm remained constantly low 
in the pH range 4-9 while the host protein content of pH 9 germ extracts was ca. 25 times 
more than that of pH 4 extracts (Gu and Glatz 2007). If expression levels comparable to 
those in germ could be reached in endosperm, then endosperm could be more appropriate for 
protein expression especially when the recombinant protein needs to be extracted at neutral 
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Table 3. 100-kDa CIα1 distributions by the dry-milling process  
* TEP: total extractable proteins in the acidic extraction condition  
** Mass yield is based on the total summation of CIα1 from all fractions (480 μg CIα1/100 g 
corn) rather than whole corn without fractionation (260 μg/100 g corn) 
 
 
 
 
 
 
 
Table 4. 44-kDa CIα1 distributions by the dry-milling process  
* Mass yield is based on the total summation of CIα1 from all fractions (2070 μg/100 g corn) 
rather than whole corn without fractionation (1650 μg/100 g corn) 
 
CIα1 TEP* Fraction Mass 
Yield  (db %) μg/g dry 
solids 
Mass Yield 
(%)** 
Purity in 
Extract (%) 
Mass Yield 
(%) 
Germ  22 15.9 63 0.29 23 
Endosperm 69 2.6 33 0.05 71 
Bran 6 3.5 4 0.07 6 
Whole 
kernel -- 2.9 -- 0.05 -- 
CIα1 TEP Fraction Mass 
Yield (db %) μg/g  
dry solids 
Mass Yield 
(%)* 
Purity in 
Extract (%) 
Mass Yield 
(%) 
Germ  27 49.6 55 0.93 30 
Endosperm 67 14.5 40 0.31 65 
Bran 5 23.9 5 0.47 5 
Whole 
kernel -- 19.2 -- 0.37 -- 
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 or alkaline pH.     
 
CIα1 Distribution in Wet-Milled Fractions 
Some similarities were observed between the two collagens. As shown in Tables 5 
and 6, both the 44-kDa CIα1 and the 100-kDa CIα1were present in all wet-milled fractions 
except for starch. About 65% of the total 100-kDa CIα1 found in the corn kernel was 
recovered in the germ, coarse fiber, and fine fiber fractions comprising 17% of the final dry 
mass (Table 7). The 100-kDa CIα1 concentrations in those fractions were 4-6 times higher 
than in the whole kernel. Similarly, 63% of the total 44-kDa CIα1was captured in the fine 
fiber, coarse fiber, and gluten meal (as opposed to germ) fractions, which accounted for 26% 
of the final dry mass. The 44-kDa CIα1 contents in both fiber fractions were concentrated 
about 10-fold compared to the whole kernel. Although both collagens were targeted to the 
germ, they were not confined in the germ fractions after wet milling. Only 3% of the 44-kDa 
and 22% of the 100-kDa CIα1 were recovered in the germ fractions. Loss from the germ is 
not surprising because the CIα1s are soluble at the steeping conditions (and significant CIα1 
is in the liquid fractions); however, it is not clear what would cause their association with 
other solid fractions. Targeting to the cell wall would give an initial cell wall association and 
the fine fiber contains cell walls. The coarse fiber (primarily bran) could still be attached to a 
portion of the germ. The suspected retention of the 100-kDa CIα1 in the ER could explain its 
greater retention in the germ (22 vs. 3%), which also suggests differences in localization 
offer the potential to influence distribution, particularly during wet milling. Still higher 
subcellular entrapment would be necessary for targeting effectiveness to be maintained 
through wet milling. The recovery of protein-free starch facilitates its use for fermentation  
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 Table 5. 100-kDa CIα1 distribution in the wet-milling process  
* Mass yield was based on the total summation of CIα1 from all fractions (302 μg/ 100 g 
corn) rather than whole corn without fractionation (260 μg/100 g corn) 
 
 
 
Table 6.  44-kDa CIα1 distribution in the wet-milling process 
* Mass yield was based on the total summation of CIα1 from all fractions (2912 μg/100 g 
corn) rather than whole corn without fractionation (1650 μg/100 g corn) 
CIα1 TEP Fraction 
  Mass Yield (db 
%) μg/g dry solids 
Mass Yield 
(%)* 
Purity in 
Extract (%) 
Mass Yield 
(%) 
Starch 58 0.1 1 - 0 
Gluten Meal 12 2.1 7 0.13 7 
Germ 6 12.7 22 0.18 16 
Pericarp 4 4.5 5 0.14 5 
Coarse Fiber 5 18.8 25 0.24 14 
Fine Fiber 6 11.5 18 0.27 9 
Steep Water 6 - 12 0.07 21 
Rinse Water 3 - 9 0.04 29 
CIα1 TEP Fraction 
 Percent (db %) μg/g dry 
solids 
Mass yield 
(%)* 
Purity in 
extract (%) 
Mass yield 
(%) 
Starch 56 0.1 0 0.9 0 
Gluten Meal 14 20.5 8 2.4 2 
Germ 2 44.0 3 0.5 4 
Pericarp 3 31.3 3 1.2 2 
Coarse Fiber 6 211.0 34 2.6 9 
Fine Fiber 6 111.3 21 4.0 3 
Steep Water 6 - 12 0.5 17 
Rinse Water 5 - 19 0.2 64 
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Table 7. Comparison of dry and wet milling (data deriving from Table 3-6)     
Process Product Fractions 
Remaining 
Solids (%) 
CIα1 
Yield (%) 
CIα1 Conc. 
(μg/g dry 
solids) 
Purity in 
Extract 
(%) 
PF*
44-kD 
Wet 
Fine/Coarse 
fiber/Gluten 26 63 84.6 2.84 7.7 
44-kD 
Wet 
Fine/Coarse 
fiber only 12 55 157.8 3.32 9.0 
44-kD 
dry Germ 27 55 49.6 0.93 2.5 
100-kDa 
Wet 
Fine/Coarse 
fiber/Germ 17 65 14.0 0.23 4.6 
100-kDa 
dry Germ 22 63 15.9 0.29 5.8 
* PF: purification factor, defined as the CIα1 purity in the extract from the fraction/ fractions 
divided by the corresponding CIα1 purity from the whole corn (without fractionation) 
  
(such as fuel ethanol).  
In the two published reports of recombinant protein partitioning during wet milling, 
Vignaux et al. (Vignaux and Johnson 2006) reported that the Escherichia coli heat-labile 
enterotoxin B subunit (LT-B) expressed in corn endosperm was also concentrated in fiber 
fractions. About 85% of glucuronidase activity was recovered in a germ fraction containing 
10% of dry mass when steeping without SO2 (Johnson and May 2003), but the SO2-free steep 
alternative did not improve the outcome (results not shown).  
Despite dispersing the CIα1s, both milling processes can increase the CIα1 purity in 
selected solid fractions. Concentration in the fiber fractions makes wet milling a feasible 
alternative; it is actually better (by measures of purity and purification factor) than the dry-
milling alternative (Table 7) though the latter’s performance could be improved by further 
processing to improve germ purity.  
While the main advantage offered by fractionation is the reduction in volume and  
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impurity load to the separation train, an initial on-farm dry-milling step would eliminate the 
need to transport viable transgenic seeds, thus reducing risk of accidental release.  
 
Conclusions 
Both dry milling and wet milling can be utilized to enrich the CIα1s and reduce the 
burden to subsequent protein extraction and purification. Dry milling allowed 50-60% of the 
total CIα1s to be captured in a germ-rich fraction making up ca. 25% of the total kernel mass. 
The recombinant protein was enriched 2.5 and 5.8 times for 44-kDa CIα1 and 100-kDa CIα1, 
respectively.  
For the wet milling, 63% of total 44-kDa CIα1 was captured in fine fiber-, coarse 
fiber-, and gluten-rich fractions which accounted for 26% of the total kernel mass, and 65% 
of total 100-kDa CIα1 was recovered in fine fiber-, coarse fiber-, and germ-rich fractions, 
which made up 17% of the total kernel mass. The recombinant protein was enriched 7.7 and 
4.6 times for 44-kDa CIα1 and 100-kDa CIα1, respectively. If only considering the fiber 
fractions, 55% of total 44-kDa CIα1 was captured in 12% of total kernel mass, with 9-fold 
enrichment, which represents a big potential for reducing the steps of the subsequent 
purification.  
While for the 100-kDa CIα1, wet and dry milling showed similar performance, for the 
44-kDa CIα1, wet milling is superior to dry milling because of greater CIα1 purity in the 
extract from the combined fiber- and gluten-rich fractions and higher purification factor (PF). 
The mechanism behind the association of the CIα1 with both coarse fiber and fine fiber 
observed in this study, as well as in the case of LT-B, was not clear. In wet milling, transport 
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via solution distributes the product to more fractions, but the clean separation of the starch 
free of proteins and oil was an advantage. Dry milling may be easier to incorporate into the 
recombinant protein production because of its simple operation, low cost and partial protein 
enrichment.  In conclusion, either milling processes could be a feasible prefractionation step 
for production of recombinant proteins.   
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CHAPTER 5. GENERAL CONCLUSIONS AND FUTURE 
WORK 
General Conclusions 
 A purification process has been developed without affinity chromatography to yield a 
pure 100 kDa CIα1 with 16% recovery from an extremely low expression transgenic source. 
The purification process included one step of membrane filtration plus four steps of 
chromatographic columns. Purification of the 44 kDa CIα1 benefited from the source 
transgenic grain having 6 times higher expression level than for the 100 kDa CIα1 that also 
made it worthwhile to separate the grain into a germ rich fraction with still higher levels.  
The result was purification in only two chromatographic steps. 
Characterization of the purified 44 kDa CIα1 demonstrated that 1) its intact protein 
mass measured by MS was within 0.2% of the mass calculated from the expected amino acid 
sequence, 2) 78% of its primary sequence was confirmed by tandem MS, 3) the first 20 
amino acid residues at the N-terminus determined by N-terminal sequencing matched that 
expected from the gene sequence, indicating the signal sequence was properly cleaved, 4) it 
was immunoreactive to an anti-25 kDa CIα1 antibody, and 5) it did not show detectable 
glycosylation. All those data provided reliable evidence that the corn-derived 44 kDa CIα1 
was consistent with the protein expressed from the recombinant DNA construct transformed 
into the corn plants and with only the intended post-translational modification. In other words, 
the results strongly indicated that corn plants were able to correctly express and process this 
single-stranded collagen fragment.   
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The transgenic corn showed less faithful expression of the longer, triple-helix version 
– the 100 kDa CIα1 collagen. Only a fraction of the corn-derived CIα1 was recovered with 
triple-helical structure. The relatively low melting temperature of the 100 kDa CIα1 (26oC vs 
40oC in native human collagen) was well correlated with its low hydroxyproline content (low 
hydroxyproline also evidenced in 44 kDa CIα1), indicating both some ability of corn to 
hydroxylate proline, but also the necessity of co-expression of a heterologous P4H if higher 
content is desired. Not unexpectedly, the C-terminal foldon was not removed, so an 
additional processing step of pepsin digestion would be needed to convert this procollagen 
form to mature collagen.  
However, the corn host did demonstrate several capabilities for producing collagen 
that go beyond the requirement of previous globular recombinant proteins expressed in corn. 
The purified 100 kDa CIα1 molecule was immunoreactive to an anti-collagen antibody, had a 
very similar molecular weight to that of an analogous CIα1 expressed in Pichia yeast, and  
46% of its primary sequence was resolved by tandem MS, confirming its identity. With some 
further optimization of gene construct and transformation (e.g. co-expression of P4H, more 
effective promoter), the plant expression system might be able to produce higher levels of 
well-processed collagens with higher melting temperature.  
Both dry and wet milling were capable of enriching the CIα1s to reduce biomass for 
the subsequent protein extraction and improve the efficiency of the purification. The 44 kDa 
CIα1 and 100 kDa CIα1 were enriched 2.5 and 5.8 times in the dry-milled germ-rich 
fractions, respectively, while they were enriched 7.7 and 4.6 times in the selected wet-milling 
fractions, respectively. Although wet milling showed higher enrichment, CIα1s were 
dispersing in several fractions. A major portion of CIα1s were unexpectedly captured in 
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fiber-rich fractions, but the high CIα1 concentration in relatively small amount of fiber 
fractions (only accounting for 11-12% of total seed biomass) makes wet milling a promising 
method for CIα1 enrichment. The separation of starch free of proteins and oil by wet milling 
was another advantage.  An initial on-farm dry-milling step would offer the additional 
advantage of eliminating the need to transport viable transgenic seed, thus reducing risk of 
accidental release. 
 
Future Work 
Although the corn plant expression system has demonstrated its potential, several 
hurdles have to be resolved for the corn to be a viable host for CIα1s expression.  
First of all, the expression level must improve hundreds of times, from current 3 mg 
of 100 kDa CIα1/ kg seeds to >1g of CIα1/ kg seeds, the accumulation level required by the 
commercial production. This high expression level is necessitated by the production cost. As 
low- or intermediate-valued recombinant proteins, the inexpensive, non-chromatographic 
methods are required, and reasonable expression level is necessary for methods such as 
precipitation to work effectively and reduce the purification cost.  
Second, the relatively low melting temperature observed in the current corn-derived 
100 kDa CIα1certainly limits its use in many applications such as pharmaceutical capsules. 
Therefore, co-expression of a heterologous P4H is necessary to achieve higher 
hydroxyproline content to form more stable triple-helical structure and increased melting 
temperature. By controlling the co-expression of P4H with CIα1, the level of proline 
hydroxylation could be tailored to suit different applications.  
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Third, fragments of 100 kDa CIα1 were observed during its purification, but it is 
uncertain whether the fragments were generated during the growth of the corn seeds, grain 
storage, or the extraction and purification process. Measures must be taken to reduce the 
fragments. If the fragments were generated during the lengthy multistep purification process 
by concomitantly released plant proteases from extraction, inhibitors could be added during 
the protein extraction. If during the synthesis of the CIα1 in seeds, gene modification might 
be needed. Again, higher expression in future generations would simplify the purification 
process and perhaps reduce the proteolytic cleavage that may have occurred during this 
lengthy purification process. 
Fourth, we observed the unexpected association of CIα1s with fibers during milling 
process, but the mechanism behind the association of CIα1s with fibers was unclear. The 
reason why the CIα1s were captured by fibers needs to be examined as there is potential for 
exploiting this as a means to enrichment. Electrostatic interaction is hypothesized to be 
involved, because the CIα1s (pI 8-9.5) are positively charged under the steeping condition 
(~pH 3.2). Zeta potential of the wet fibers during milling could be measured to determine if 
they possess negative charge that would support this hypothesis. 
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